relentless cures for the - leukemia & lymphoma society · relentless about raising the money...

2000 Annual Report

Curesfor the

Relentless

We added the word “lymphoma” to our name last year to bring into

focus the full scope of our mission–fighting all hematological

malignancies. The Society was further motivated by a startling rise

in lymphoma incidence rates over the last two decades. For all these

blood-related cancers, we have been, and will continue to be,

relentless for the cures.

Ourmissi

Our name

Cure leukemia, lymphoma, Hodgkin’s

disease and myeloma, and improve

the quality of life of patients and

their families.

w w w . l e u k e m i a - l y m p h o m a . o r g

onStatus of blood related cancers:

LeukemiaWe’re winning the battle…The five-year survival rate for leukemiapatients has tripled from 14% in1960, to 44% in 1995. The five-yearsurvival rate for children with acutelymphocytic leukemia is 81%.

But the war isn’t over…This year inthe U.S., an estimated 30,800 newcases of leukemia will be diagnosed,and approximately 21,700 people willdie from the disease.

LymphomaWe’re winning the battle… The five-year survival rate for non-Hodgkin’slymphoma patients rose from 31% in 1960 to 52% in 1995. In children,the five-year survival rate is 78%, asignificant improvement in the last30 years.

Survival rates

100

%

90

%

80

%

70

%

60

%

50

%

40

%

30

%

20

%

10%

0%

Surv

ival

rat

es

But the war isn’t over… About62,300 Americans will be diagnosedwith lymphoma in 2000, the vastmajority with non-Hodgkin’slymphoma. An estimated 27,500people will die from lymphoma in 2000, the majority from non-Hodgkin’s lymphoma.

MyelomaWe’re making progress… Thesurvival rate for myeloma is 28%, amodest improvement from 24% inthe 1970s.

But there’s much more we need todo… An estimated 13,600 new casesof myeloma will be diagnosed in theU.S. in 2000, and approximately11,200 people will die from it.

Leukemia

Non-Hodgkin’s Lymphoma

Hodgkin’s Disease

Myeloma

1960 1995

3

14%44%

31%52%

40%83%

<5%28%

Sources: National Cancer Institute Seer Data; Myeloma: Biology andManagement, 2nd Edition, Oxford University Press, 1998.

Take a look at the Society’s researchprograms. The relentless pursuit of cures can be found, for example, in the promising therapy developed by Dr. Brian Druker to treat chronicmyelogenous leukemia. All 31 patientstreated in the initial clinical trials have had their blood counts return to normal, so the trials have expanded to more than 1,500 patients—and we are very optimistic.

Take a look at our new SCOR program(Specialized Center of Research), with $22.5 million targeted to three groups ofscientists working cooperatively on a range of research to fight blood-relatedcancers. We expect to triple this programover the next few years.

In patient services, you’ll find “relentless” in the Information Resource Centerprograms—lifelines of emotional supportand timely professional guidance for tens of thousands of patients. And through itsweb site and the Internet, the Societyspeeds the delivery of vital information and services, and engages patients andvolunteers more efficiently. In a very real sense, the Internet is providing the Society with an increasing presence andgreater capacity to expand the reach of its mission.

The supporters of the Society are alsorelentless about raising the money thatfuels these programs, having increased the Society’s net revenue by 24% this yearto a record $133.4 million. In fact, in terms

Relentless for the curesRelentless for the cures. It means that nothing will stand in the way of those determined to

carry out the Society’s mission. The record this year, as well as future plans, attest to this

ongoing commitment.

Relefor the cur


Society Officers (l-r)Jay L. Silver, Chairman; Richard A. Fess,Secretary/Treasurer; Dwayne Howell,President and CEO; W. Stratford May, Jr.,MD, PhD, Vice Chairman, Medical andScientific Affairs; Peter J. Quesenberry,MD, Vice Chairman.

4

of share of donations raised, the Societycontinues to be the fastest growingnationwide voluntary health organizationin the U.S. How did we get there? Look at the national Light The Night® Walkcampaign, which raised $5 million in fiscalyear 2000 and nearly twice that amountthis year. Or talk to people like HarryPearce, Vice Chairman of General Motors,who is launching a personal campaign toraise millions of new dollars for research.

Of course, nothing says relentless morethan Society volunteers—individuals,families and business owners, trustees at every chapter, and even renowned scientists who spend countless hours of“free” time assessing research proposals.

(l-r) Richard A. Fess, Peter J. Quesenberry, MD, Jay Silver, Dwayne Howell, W. Stratford May Jr., MD, PhD

ntlesses

5

Today, more people are surviving blood-related cancers than ever before, but it’s not enough. With powerful new tools and a growing array of new programs andservices, the volunteers and staff of theSociety are truly relentless for the cures.Nothing will stand in their way.

Jay L. SilverChairman

Dwayne HowellPresident and CEO “The Society continues to

be the fastest growing

nationwide voluntary health

organization in the U.S.

”

Strenresearch

In addition to the three grants designatedfor 2000 - 2001, the Society is committed tofunding six more SCOR grants over thenext three years, amounting to a total of$67.5 million in team-based research.

These grants are designed to bring togetherprograms that share a common researchfocus and attack the same scientificproblems. With scientists from differentdisciplines working in concert, the researchcommunity will have a better chance todevelop cures and achieve significantlyhigher survival rates.

The SCOR at Weill Medical College ofCornell University will focus on myeloma,an incurable cancer of the antibody-producing plasma cells. The team will work to understand the genetic basis of this cancer, control the accumulation of malignant cells and prevent bonedestruction caused by the myeloma.

The SCOR at Dana-Farber Cancer Institute will concentrate on developingcurative therapies for acute and chronicmyelogenous leukemias by providing ways to translate laboratory research into novel approaches for diagnosis and treatment.

Strengthening research—the SCOR grants

• Support research programs by volunteeringwith the Society

• Raise and contribute funds for research

The Leukemia & Lymphoma Society’s new Specialized Center of Research (SCOR) Program

will provide $22.5 million in research grants over five years, to three groups of outstanding

scientists working on blood-related cancers.

Marshall A. Lichtman, MD,Executive Vice President, Researchand Medical Programs


6

How you can help

gthening

The SCOR at Oregon Health SciencesUniversity, in collaboration with scientists atthe M.D. Anderson Cancer Center and theUniversity of California at Los Angeles, willfocus on chronic myelogenous leukemia(CML) and a compound known as STI-571,which has had remarkable success in puttingCML patients into remission in recent clinicaltrials. This center will work to determine thecauses of CML and how to best use STI-571 as a treatment.

Marshall Lichtman, MD, congratulates SCOR awardees (l-r): James D. Griffin, MD, Dana-Farber Cancer Institute; Selina Chen-Kiang, PhD, Weill Medical College, Cornell University; Brian J. Druker, MD, Oregon Health Sciences University

”“ Scientists from different

disciplines working together

will have a better chance to

develop cures and achieve

higher survival rates.

7


8

Thanks to the Society’s

research efforts, the

survival rate for children

with acute lymphocytic

leukemia is 81%.

The Career Development Program providesfunding for the most promising youngscientists. Currently, the Society supports129 Fellows and 153 Special (advanced)Fellows who work with outstanding seniorscientists to uncover the mysteries of thegenes, molecules, and aberrant cell systemsthat lead to blood-related cancers.

In addition, 88 Scholars are supported bythe Career Development Program. Thesescholars are young, independent scientistsbringing the most recent technologies and

new ideas to the laboratory. To furthertranslate gains in basic knowledge to anincrease in cure rates, the Society alsoinitiated a variation of its Scholar Program,known as Scholars in Clinical Research.Since it began three years ago, thisprogram has funded 13 scientists.

Recognizing that the movement of basicresearch to clinical application is the final pathway to cures, the Society alsocontinues to expand its TranslationalResearch Program. The funding ofresearch on STI - 571 in the treatment of chronic myelogenous leukemia (CML) is an example of the Society’sinvestment in new and promisingtranslational research.

In fiscal 2000, 131 Translational grantswere supported, offering potentially new approaches to chemotherapy,immunotherapy, and stem celltransplantation.

Strengthening research— $200 million and counting

While the SCOR grants are the newest and largest additions to the Society’s research effort,

more than $200 million in grants have been awarded since the Society’s founding. In fact,

research expenditures have more than doubled over the last three years, to $32 million in

2000, in support of broad-based studies targeted to increase cure rates.

(l-r) Peter J. Quesenberry, MD; W. Stratford May, Jr., MD, PhD;Marshall A. Lichtman, MD

Research Funding Growth 1996-2000(in millions)

20

00

199

9

199

8

1997

199

6Res

earc

h gr

owth

5

10

15

20

25

$11.6

$14.9

$20.0

$23.5

$32.0

9

From conducting Family Support Groupsto helping children make a smoothtransition from treatment back to school,the Society is deeply committed to reachingevery patient and family with services thatimprove their lives.

In 2000, for example, the Society’sInformation Resource Center (1-800-955-4572) connected more than35,000 patients, caregivers and healthcareprofessionals to the IRC’s skilled nursesand social workers. The IRC staff providestimely information and referrals, includingdata on diagnoses, treatment options andclinical trials, as well as guidance onsecond opinions and counseling.

For the newly diagnosed patient, FirstConnection is a lifeline to a trained peer who understands the feelings andneeds first-hand. In 2000, more than 2,200 individuals took advantage of thisservice, a figure that is expected to increase substantially.

Through a collaboration with the NationalCoalition for Cancer Survivorship, andsupported by an educational grant fromOrtho Biotech, the Society offers “Cancer:Keys to Survivorship,” a seminar providingempowering information and tools.Participants learn about communicatingeffectively with healthcare providers,strategies for self-empowerment and self-care, obtaining and collecting healthinsurance benefits, and employment rights issues.

A new educational symposium also aimedat assisting patients is “Improving theChemotherapy Experience.” Supported byAmgen, Inc., ICE is designed to helpchemotherapy patients help themselvesphysically and emotionally through thechallenge of treatment.

Extending our reach to patients and communities

Support, understanding and knowledge–they go a long way to help patients battle

blood-related cancers. Nowhere are these qualities more concentrated and effective than

in the Society’s expanding array of patient and community service programs.

Extendiour

Hildy Dillon (standing), SeniorDirector, Information Resource Center;Tammi Haber, Senior Specialist,Health Care Navigation


10

ng reach

David G. Poplack, MD, Chairman, Patient Services Committee; Robin Kornhaber,Vice President, Patient Services

”“ The Society is deeply

committed to reaching

every patient and family

with services that

improve their lives.

11

• By providing a targeted series of psychosocialand practical services

• By supporting patients, from diagnosisthrough treatment and recovery

How we help

As a result, many Members of Congresshave become engaged in Society programsand have gained a greater appreciation ofthe Society’s goals and the role they canplay in achieving them.

After several years of legislative appeals by Society advocates, President Clintonannounced on June 7 that Medicare wouldbegin covering the routine care costs ofclinical trials, including meals, beds andnursing services.

With the helpful prodding of Societyadvocates, the National Cancer Instituteinitiated a Progress Review Group onblood-related cancers, which includesSociety members, to help look forpromising new research opportunities that the NCI could support.

Meanwhile, the Society continues to forgealliances with various groups in order tostrengthen its hand with policymakers. Aspart of the National Health Council, the

Cancer Leadership Council, One VoiceAgainst Cancer and The IndependentSector, the Society exerts a strongerinfluence on issues of common interest.

Looking ahead, the Society’s Public Policyoffice in Washington has been strengthenedto help volunteers keep up with legislativedevelopments and facilitate swift andtargeted action. The Society’s web site andits Legislative Action Center are part of this effort. New recruitment materials andissue briefs, a stronger training curriculumand a broader policy agenda have alsobeen designed to engage and mobilize volunteer-advocates.

Increasing our influence through advocacy

With almost 3,000 volunteers, the Society’s Advocates Network is a powerful voice on

behalf of patients, speaking out to legislators and other government leaders on such issues

as medical research funding, insurance coverage and access to care.


President Clinton recognizes Leukemiaand Lymphoma Awareness Month(September) in the Oval Office withSociety President and CEO DwayneHowell and several young patients.

”“ Legislators and

government officials are

gaining a greater

appreciation of their role

in helping the Society

achieve its goals.

12

(l-r) Frank T. Short, Chairman, PublicPolicy Committee; George Dahlman,Vice President, Public Policy

• Join the Society’s Advocates Network

• Learn about legislative issues affectingpatients

• Help speak out for patients and their families

• Keep up with developments on Capitol Hill

• Respond to "calls-to-action" by contactinglegislators and expressing your concernabout important issues

How you can help

13

Growing oreven

Through Team In Training®, the Society’slargest fundraising effort, volunteers raisefunds running, walking, cycling andswimming, as they train to participate inprestigious endurance events.

The Light The Night® Walk is anotherdynamic fundraising and awarenesscampaign. In its second year as a nationalevent, Light The Night was held at over170 sites in September 2000, up from 100in 1999. Result: revenues nearly doubled.

Other grassroots events that are growingsignificantly include the School & YouthTM

Programs. Through such programs as“Pasta for Pennies” sponsored by Olive

Garden Restaurants, “Pennies for Patients”and “Hop for Leukemia,” school childrenraised nearly $9 million in fiscal 2000,while reaping the personal reward ofhelping people.

Meanwhile, major gifts from individuals,corporations and foundations continue tobe a vital source of support. Harry Pearce,Vice Chairman of General Motors, is takinghis own successful battle with leukemiafrom the hospital to the boardroom. Notonly is GM leading the way with a $1.5million grant for the SCOR program, butMr. Pearce is launching a personal crusadeto raise millions of new research dollarswith his Journey of Hope Major Gift

Growing our revenue baseCures can be found only with more research. More research can take place only

with more revenue. And so, the Society has been relentlessly growing its revenue

base, which increased by 24% in 2000.

Harry Pearce, Vice Chairman ofGeneral Motors, launched a personalcrusade to raise millions of dollars forresearch, including a $1.5 milliongrant from GM for the SCOR program.


14

ur ue

• Make a personal gift to the Society

• Become a participant and enlist yourbusiness or employer in Light The Night® Walk

• Take on the challenge of Team In Training®

• Volunteer for fundraising events through your local Society chapter

• Include the Society in your will

• Make a donation in the name of someone you love

Campaign. Also joining the crusade are Tom and Sandy Bertelsen of California. TheBertelsens are supporting a SCOR project ledby Dr. Brian Druker, which focuses on findingcures for CML.

How you can help

(l-r) David S. Dimling, Chairman, Fundraising Committee; Richard J. Geswell,Senior Vice President, Revenue Development

Net Revenue Growth 1996-2000(in millions)

20

00

199

9

199

8

1997

199

6Rev

enue

gro

wth

20

40

60

80

100

$49.8$58.2

$83.8

$107.2

$133.4

120

15

• Participate in one of the Society’s majorevents through your local chapter

• Make a contribution when you receive directresponse fundraising materials

• Speak out about the good work of theSociety to your friends and neighbors

How you can help


16

In the public relations arena, the Society is contacting leading medical and scientificwriters and reporters about the volumeand nature of Society-funded research andpatient services. The focus in 2000 is onthe new Specialized Center of Research(SCOR) Program, which generates interestas significant news and builds a foundationfor ongoing media relations.

Meanwhile, the Society reached more than 18 million households and smallbusinesses through a campaign of directmail, telemarketing, neighborhood drivesand e-marketing. In addition to raisingfunds, these campaigns inform thepublic about blood-related cancers and Society programs.

Media events also help spread the word to millions of people while raising funds.Annual events include syndicated talk show host Rush Limbaugh’s annual radiocampaign, and the “Chase to the Cure”television special, broadcast in New York on WPIX-TV and sponsored by ChaseManhattan Bank. In Fall 2000, new publicservice announcements featuring celebrityCindy Crawford, a trustee of the New York City Chapter, also began hitting theairwaves around the country.

Advertising and promotions supportingmajor Society events also go a long way to increase participation and enhanceawareness. Ads in national magazineshelped to draw nearly 30,000 participantsfor Team In Training®, and public serviceannouncements on TV reached millions of viewers. Light The Night® Walk drewnearly 50,000 participants, and millions of people to the Society’s Light The NightWalk message, thanks to related magazineand internet ads and web site hits.

The Leukemia & Lymphoma Society uses a number of marketing and

communications tools to increase public awareness about the organization’s

mission, and to help raise funds.

Cindy Crawford, a trustee of the New York Citychapter, speaks out in theSociety’s public serviceadvertising campaign.

Increasing public awareness

(l-r) Norbert J. Sieber, Chairman, Marketing and Communications Committee;Robert K. Wehrmann, Senior Vice President, Marketing and Strategy Development

17

Adour missi

Without volunteers, the Society’s relentlesspursuit of cures for blood-related cancerswould be stopped cold. Meanwhile, thestaff provides the support and technicalexpertise to volunteers, which result inhigh-quality and productive programs and events.

At all 58 chapters, volunteer trustees joinstaff to provide the leadership, strategicplanning, community organizing andrecruitment skills to achieve the Society’sgoals. This past year, new guidelines were

introduced to challenge trustees to makethe highest impact possible—in accessingresources in their communities, advancingthe Society’s mission, and ensuring theongoing health and productivity of theorganization.

Only with high-impact boards, working inconjunction with staff, can the job ofattracting, training and mobilizing tens ofthousands of volunteers be accomplished.These are the people who organize events,answer phones, support healthcare

• Volunteer at your local Society chapter

• Help to recruit other volunteers

• Recommend community leaders to serve aschapter trustees

• Participate in local programs and events

The dynamic partnership between volunteers and staff is a critical element in

advancing the Society’s mission. Volunteers—from the national board and local

trustees, to scientists contributing their time and talents to identify the most

promising research, to local event organizers and participants—bring passion

and enthusiasm in all they do.

How you can help

Advancing our mission throughvolunteer-staff partnership

Staff members of the Fairfield County (Connecticut) Chapter wrap up a meeting.

18


vancingon

professionals in patient service programs,advocate for research funding to state and local officials, and reach out to thecommunity in innumerable ways.

The volunteer-staff partnership fuels theSociety’s mission, enabling everyone towork better and smarter to advance theSociety’s relentless quest to find cures forall blood-related cancers.

(l-r) Paul Weiss, Senior VicePresident, Chapter Development;Lynn C. Hoover, Chairman,Chapter Development Committee

”“The volunteer-staff

partnership fuels the

Society’s mission to find

cures for all blood-

related cancers.

19

(l-r) Donald H. Salsbery,Chairman, AdministrationCommittee; Cynthia GardnerCross, Vice President,Administration

Building a stronger


To make sure everyone is working aseffectively and efficiently as possible, the Society continues to strengthen itsinfrastructure and foster a team-basedenvironment that motivates both staff and volunteers alike.

This year’s Home Office move to WhitePlains, New York, for instance, helps tomeet those objectives by optimizing officespace while minimizing costs, enhancingrecruitment efforts and centralizing on-site training—so that staffers andvolunteers from around the country canreap the benefit of face-to-face interactions with colleagues.

Training, networking and recognitionprograms are also key components ofbuilding a stronger team. The AnnualLeadership Conference and the AnnualProfessional Conference, for example,

enable regional and chapter leaders, keystaff and volunteers to learn, share ideas,and reward excellence, so they can meettheir respective challenges refreshed and motivated.

The Internet opportunity

Nothing, however, will be a greater team-building tool than the Internet. Already in2000, more than a million people contactedthe Society through its web site, a numberthat’s expected to triple in the next year.

With new Internet capabilities coming on line in early 2001, the Society’s web site will be an even more dynamicresource, reaching, engaging and deliveringindividualized services to millions of people immediately—any time, anywhere.For patients, their families, volunteers,healthcare professionals, donors and others,the site will offer high levels of interaction,customization, rich content and links tochapters and other relevant sites.

Building a stronger team for the future

People who work for The Leukemia & Lymphoma Society know they are making

a difference in the battle against blood-related cancers. It’s not just a job, but a

passionate commitment.

20

team

When a visitor provides an e-mail addressand a profile of interest, the Society will beable to offer that visitor an individualized“home page” for receiving the latestinformation, program updates and clinicalnews that match his or her specific needs. This capability will empower patients, for example, with the latest medicalinformation and guidance to ensure thebest treatment for their disease.

The visitor’s home page will also be able to archive pertinent video presentations,teleconferences and other educationalsessions. Additionally, the web site willoffer online registration and instruction,and direct support to those who want toparticipate in advocacy, fundraising andother programs that strengthen theSociety’s mission.

• Find out about career opportunities at the Society

• Get comfortable with the Internet

• Promote the use of information technology

• Explore the Society’s website and referothers to it

How you can help

For chapter offices, these new capabilitieswill provide a centralized, “turnkey”infrastructure. With a simple PC andInternet access, chapters will be fullyconnected to the rest of the organization,yet be able to tailor web site informationon their activities and events.

21

John Walter, Senior Vice President,Finance and Information Technology

(l-r) John Walter, Senior Vice President, Finance and Information Technology;William S. Lear, Chairman, Internet Committee

Andrew E. Nolan, Chairman, Finance Committee

Research grants—SCOR and Career Development Program

Specialized Center of Research 1

Selina Chen-Kiang, PhD – 20 0 0Weill Medical College of Cornell Un i v e rs i t y

Brian J. Druker, MD – 2000 2

Oregon Health Sciences Un i v e rs i t y

James D. Griffin, MD - 20 0 0D a n a - Fa r ber Cancer Institute

Career Development Progra m —S c h o l a r s

Paul J. Anderson, MD – 199 5B righam and Wo m e n ’s Hos p i t a l

Donald E. Ayer, PhD – 1998Un i v e rsity of Ut a h

Ravi Basavappa, PhD – 1999Un i v e rsity of Roch es t e r

Ti m o t hy W. Behrens, MD – 1997Un i v e rsity of Minnes o t a

Mark Boothby, MD, PhD - 199 5Vanderbilt Un i v e rsity School of Medicine

Katherine Borden, PhD – 20 0 0Mount Sinai School of Medicine

Emery H. Bresnick, PhD – 1997Un i v e rsity of Wisconsin Medical Sch o o l

Stephen Buratowski, PhD – 1999H a rvard Medical Sch o o l

Frederic D. Bushman, PhD – 1996Salk Institute for Biological Studies

Don Chen, PhD – 20 0 0Un i v e rsity of Massachusetts Medical Sch o o l

Genhong Cheng, PhD – 20 0 0Un i v e rsity of California, Los Angeles

Jonathan Chernoff, MD, PhD – 1997Fox Chase Cancer Center

K. M. Coggeshall, PhD – 1998Oklahoma Medical Res e a r ch Fo u n d a t i o n

Alan D. D’Andrea, MD – 199 5D a n a - Fa r ber Cancer Institute

George O. Daley, MD, PhD – 1999 3

Whitehead Institute for Biological Res e a r ch

James A. DeCaprio, MD – 1997D a n a - Fa r ber Cancer Institute

James DeGregori, PhD – 20 0 0Un i v e rsity of Colorado Health S c i e n c es Center

Laurence C. Eisenlohr, VMD, PhD – 1999Thomas Jefferson Un i v e rs i t y

Mark E. Ewen, PhD – 1997D a n a - Fa r ber Cancer Institute

Carolyn A. Felix, MD – 1996C h i l d r e n ’s Hospital of Philadelphia

Alan Pa t r i ck Fields, PhD – 199 5Un i v e rsity of Texas, Galves t o n

Susan L. Forsburg, PhD – 1997Salk Institute for Biological Studies

Alan D. Friedman, MD – 1998Johns Hopkins Un i v e rsity School of Medicine

Xiang-Dong Fu, PhD – 1997Un i v e rsity of California, San Diego

Peter M. Glazer, MD, PhD – 1996Yale Un i v e rs i t y

M i chael J. Grusby, PhD – 1997H a rvard School of Public Health

Wendy L. Havran, PhD – 1996The Scripps Res e a r ch Institute

Philip W. Hinds, PhD – 199 5H a rvard Medical Sch o o l

Jae Jung, PhD – 20 0 0H a rvard Medical Sch o o l

A n t h o ny N. Imbalzano, PhD – 1999Un i v e rsity of Massachusetts Medical Center

Y. To ny Ip, PhD – 1996Un i v e rsity of Massachusetts Medical Center

Mark P. Kamps, PhD – 1997Un i v e rsity of California, San Diego

Nigel Killeen, PhD – 20 0 0Un i v e rsity of California, San Fr a n c i s c o

M i chael Koelle, PhD – 1999Yale Un i v e rs i t y

Sally Kornbluth, PhD – 1998Duke Un i v e rsity Medical Center

D avid Lambright, PhD – 1998Un i v e rsity of Massachusetts Medical Center

H yam I. Levitsky, MD – 1997Johns Hopkins Un i v e rsity School of Medicine

Daniel I. Lew, PhD – 20 0 0Duke Un i v e rsity Medical Center

Jonathan D. Licht, MD – 199 5Mount Sinai School of Medicine

Paul Lieberman, PhD – 1997The Wistar Institute

Hsiou-Chi Liou, PhD – 20 0 0Weill Medical College of Cornell Un i v e rs i t y

R i chard M. Longnecker, PhD – 199 5 4

N o r t h w es t e rn Un i v e rsity School of Medicine

Kun Ping Lu, MD, PhD – 1998Beth Israel Deaconess Medical Center

R i chard S. Mann, PhD – 1997Columbia Un i v e rsity Health Sciences

Garry P. Nolan, PhD – 199 5Stanford Un i v e rsity School of Medicine

Giuseppina Nucifora, PhD – 1998L o yola Un i v e rsity of Chica g o

Matthew J. O’Connell, PhD – 20 0 0Peter MacCallum Cancer Institute

Marjorie Oettinger, PhD – 1996M a s s a chusetts General Hos p i t a l

Pier Paolo Pandolfi, MD, PhD – 1997 5

M e m o rial Sloan-Ke t t e ring Cancer Center

Susan M. Parkhurst, PhD – 199 5Fred Hutchinson Cancer Res e a r ch Center

Waren S. Pear, MD, PhD – 1998Un i v e rsity of Pe n n s y l v a n i a

D avid S. Pellman, PhD – 20 0 0D a n a - Fa r ber Cancer Institute

B. Franklin Pugh, PhD – 1996Pennsylvania State Un i v e rs i t y

D avid J. Rawlings, MD – 1999Un i v e rsity of California, Los Angeles

Ruibao Ren, MD, PhD – 1998Brandeis Un i v e rs i t y

Erle S. Robertson, PhD – 1999Un i v e rsity of Mich i g a n

Barrett J. Rollins, MD, PhD – 199 5D a n a - Fa r ber Cancer Institute

D avid Ron, MD – 1996 6

New York Un i v e rsity Medical Center

Paul Rothman, MD – 199 5Columbia Un i v e rs i t y

Moshe J. Sadofsky, MD, PhD – 1999M e d i cal College of Georgia

Kathleen M. Sakamoto, MD – 1998Un i v e rsity of California, Los Angeles

Charles L. Saw yers, MD – 199 5Un i v e rsity of California, Los Angeles

Christian W. Schindler, MD, PhD – 1996Columbia Un i v e rs i t y

Mark Schlisel, MD, PhD – 1996Un i v e rsity of California, Berkeley

E d ward W. Scott, PhD – 1998Un i v e rsity of Pe n n s y l v a n i a

D avid C. Seldin, PhD – 20 0 0B oston Medical Center

Margaret A. Shipp, MD – 199 5D a n a - Fa r ber Cancer Institute

Ramesh A. Shivdasani, MD, PhD – 20 0 0D a n a - Fa r ber Cancer Institute

Gerald Siu, PhD – 20 0 0Columbia Un i v e rsity Health Sciences

Tomasz Skorski, MD, PhD – 20 0 0Temple Un i v e rs i t y

Andreas Strasser, PhD – 1997The Walter and Eliza Hall Institute

M i chel Streuli, PhD – 1997D a n a - Fa r ber Cancer Institute

Charles D. Surh, PhD – 1999The Scripps Res e a r ch Institute

Guillermo E. Taccioli, PhD – 1998B oston Un i v e rsity School of Medicine

1 The Special Center of Research Grant Program issupported in part by a generous gift from GeneralMortors Foundation.

2 The Special Center of Research Grant of Dr. BrianJ. Druker is funded in part by a generous gift fromThe Bertelsen Family.

3 Dr. Daley, a Stephen Birnbaum Scholar, is fundedby a generous gift to the Society from The StephenBirnbaum Foundation.

4 Dr. Longnecker is supported in part by generousgifts to the Society from the Berner Charitable &Scholarship Foundation and the Helen V. BrachFoundation.

5 Dr. Pandolfi is supported by a generous gift to the Society from The Reichman Memorial and TheAltshul Foundation.

6 Dr. Ron, a Stephen Birnbaum Scholar, isfunded by a generous gift to the Society fromThe Stephen Birnbaum Foundation.

Tse-Hua Tan, PhD – 1996Baylor Un i v e rsity College of Medicine

Dimitris Thanos, PhD – 20 0 0Columbia Un i v e rs i t y

Sheila M. Thomas, PhD – 1999Beth Israel Deaconess Medical Center

R i chard A. Van Etten, MD, PhD – 1998H a rvard Medical Sch o o l

D avid L. Van Vactor, PhD – 20 0 0H a rvard Medical Sch o o l

D avid L. Vaux, MD, PhD – 1999The Walter and Eliza Hall Institute

Catherine Verfaillie, MD – 199 5Un i v e rsity of Minnes o t a

Jane Y. Wu, PhD – 1998 7

Washington Un i v e rs i t y

Tim J. Yen, PhD – 199 5Fox Chase Cancer Center

Kyo ko Yo komori, PhD – 20 0 0Un i v e rsity of California, Irv i n e

Faith M. Young, PhD – 1998Un i v e rsity of Roch es t e r

Dong-Er Zhang, PhD – 1998The Scripps Res e a r ch Institute

Liang Zhu, MD, PhD – 1999A l bert Einstein College of Medicine

Yuan Zhuang, PhD – 1998Duke Un i v e rsity Medical Center

Career Development Progra m —Scholars in Clinical Re s e a r c h

Robert Brodsky, MD – 20 0 0Johns Hopkins Un i v e rsity School of Medicine

R i chard K. Burt, MD – 1998 8

N o r t h w es t e rn Un i v e rs i t y

Jorge Cortes, MD – 20 0 0Un i v e rsity of Texas, Houston

Glenn Dranoff, MD – 20 0 0D a n a - Fa r ber Cancer Institute

Ti m o t hy Jon Ernst, MD – 1998 9

B oston Un i v e rsity School of Medicine

S t e ven D. Gore, MD – 1998Johns Hopkins Un i v e rsity School of Medicine

Mary Joan Laughlin, MD – 1998Case Wes t e rn Res e rve Un i v e rs i t y

Jane L. Liesveld, MD – 1998Un i v e rsity of Roch es t e r

Dana C. Mathews, MD – 1999Fred Hutchinson Cancer Res e a r ch Center

Nikhil C. Munshi, MD – 1998Un i v e rsity of Arkansas for Medical Sciences

Robert J. Soiffer, MD – 1999D a n a - Fa r ber Cancer Institute

Edmund K. Waller, MD, PhD – 1998E m o ry Un i v e rs i t y

Christopher Walsh, MD, PhD – 20 0 0Un i v e rsity of North Carolina, Chapel Hill

Career Development Progra m —Special Fe l l o w s

Ricardo C.T. Aguiar, MD, PhD – 1999D a n a - Fa r ber Cancer Institute

Nicole Schreiber Agus, PhD – 1997A l bert Einstein College of Medicine

Ashok Aiyar, PhD – 1999Un i v e rsity of Wisconsin, Madison

S. Munir Alam, PhD – 1998The Scripps Res e a r ch Institute

Edwin P. Alyea, MD – 1998D a n a - Fa r ber Cancer Institute

Lee Bardwell, PhD – 1997Un i v e rsity of California, Berkeley

Christopher Thomas Beh, PhD – 1999Un i v e rsity of California, Berkeley

Robert J. Benschop, PhD – 1998National Jewish Medical & Res e a r ch Center

Fred Bertrand, PhD – 1999 10

Un i v e rsity of Minnes o t a

A n j a - Katrin Bielinsky, PhD – 1999 11

Brown Un i v e rs i t y

D avid Bilder, PhD – 20 0 0H a rvard Medical Sch o o l

Daniel Denis Billadeau, PhD – 1999M a yo Clinic

S tacy W. Blain, PhD – 1999 12


Peter Blume-Jensen, MD, PhD – 1998The Salk Institute for Biological Studies forB i o l o g i cal Studies

M i chael Boddy, PhD – 20 0 0The Scripps Res e a r ch Institute

Aleksey Bortvin, MD, PhD – 1999Whitehead Institute

Julie A. Brill, PhD – 1997Stanford Un i v e rsity School of Medicine

Grant W. Brown, PhD – 1998Johns Hopkins Un i v e rsity School of Medicine

Mary E. Bryk, PhD – 1998H a rvard Medical Sch o o l

Donald Andrew Burden, PhD – 1998Vanderbilt Un i v e rs i t y

Fernando Casares, PhD – 20 0 0Columbia Un i v e rs i t y

Lucio H. Castilla, PhD – 1999National Institutes of Health

C h i n g -Ye Chen, PhD – 1999Un i v e rsity of California, San Diego

Po Chen, PhD – 20 0 0Un i v e rsity of Texas, Dallas

Sim-Bee Cheng, PhD – 1997The Scripps Res e a r ch Institute

Margaret Mary Chou, PhD – 1997Un i v e rsity of Pe n n s y l v a n i a

Chang Y. Chung, PhD – 20 0 0Un i v e rsity of California, San Diego

Yolonda L. Colson, MD, PhD – 1997D a n a - Fa r ber Cancer Institute

Barbara Conradt, PhD – 1997Max Planck Institute

Crislyn D’Souza-Sch o r e y, PhD – 1997Washington Un i v e rs i t y

Zonghan Dai, PhD – 1997Un i v e rsity of Colorado

Beatrice D. Darimont, PhD – 1999Un i v e rsity of California, San Fr a n c i s c o

Charles J. DiComo, PhD – 20 0 0M e m o rial Sloan-Ke t t e ring Cancer Center

A b by F. Dernburg, PhD – 1999 13

Stanford Un i v e rsity School of Medicine

H a n - Fei Ding, MD, PhD – 1998D a n a - Fa r ber Cancer Institute

Mensur Dlakic, PhD – 20 0 0Un i v e rsity of Mich i g a n

R i ck A. Fi n ch, PhD – 1998Yale Un i v e rs i t y

Claire Francastel, PhD – 20 0 0Fred Hutchinson Cancer Res e a r ch Center

D avid A. Fruman, PhD – 1998Beth Israel Deaconess Medical Center

Hironori Funabiki, PhD – 1999Un i v e rsity of California, San Fr a n c i s c o

Guangxia Gao, PhD – 20 0 0Columbia Un i v e rsity Health Sciences

Irene Garcia-Higuera, PhD – 20 0 0D a n a - Fa r ber Cancer Institute

Paul A. Garrity, PhD – 1997M a s s a chusetts Institute of Te ch n o l o g y

Stefan Gaubatz, PhD – 1999D a n a - Fa r ber Cancer Institute

Scott Goode, PhD – 1997Baylor Un i v e rsity College of Medicine

Atan Gross, PhD – 1999D a n a - Fa r ber Cancer Institute

Thomas M. Guadagno, PhD – 1998Stanford Un i v e rsity College of Medicine

Mounou Hahn, PhD – 1998Un i v e rsity of California, San Fr a n c i s c o

Hisashi Harada, PhD – 1998D a n a - Fa r ber Cancer Institute

Hanno Hock, PhD – 1999C h i l d r e n ’s Hospital Bos t o n

7 Dr. Wu is supported by a generous gift to the Society from the Mary & Robert BronsteinMemorial Endowment Fund.

8 Dr. Burt is supported in part by generous gifts to the Society from The Coleman Foundation, The Grant Healthcare Foundation, and the Dr. Scholl Foundation.

9 Dr. Ernst, a Stephen Birnbaum Scholar for ClinicalResearch, is funded by a generous gift to the Societyfrom The Stephen Birnbaum Foundation.

10 Dr. Bertrand is supported by a generous gift tothe Society from The Chris P. Tkalcevic Foundation.

11 Dr. Bielinsky is funded by a generous gift to theSociety from Leslie Elliot Krause, Esq.

12 Dr. Blain is supported by a generous gift fromDrs. Emile and Vivian Sandler in honor of Zvi Fuchsof the Sloan-Kettering Radio/Oncology Department.

13 Dr. Dernberg is supported by a generous gift tothe Society from Pete Harman.

Research grants—Career Development Program

Linda S. Huang, PhD – 1999Un i v e rsity of California, San Fr a n c i s c o

D avid Ching Siang Huang, MD – 1998The Walter and Eliza Hall Institute

Paul Hughes, D Phil – 1997The Scripps Res e a r ch Institute

Jorge A. Iniguez-Lluhi, PhD – 1997Un i v e rsity of California, San Fr a n c i s c o

B r yan A. Irving, PhD – 1999 14

Un i v e rsity of California, San Fr a n c i s c o

Feng Jiang, PhD – 1997M e m o rial Sloan-Ke t t e ring Cancer Center

Jin Jiang, PhD – 1998Un i v e rsity of Texas, Galves t o n

Claudio Joazeiro, PhD – 20 0 0The Salk Institute for Biological Studies

Steffen Jung, PhD – 1999Skirball Institute

Kenneth B. Kaplan, PhD – 1997M a s s a chusetts Institute of Te ch n o l o g y

Mark H. Kaplan, PhD – 1997Indiana Un i v e rs i t y

Barbara L. Kee, PhD – 1998Un i v e rsity of California, San Diego

Sepideh Khorasanizadeh, PhD – 1998HHMI, Un i v e rsity of Mary l a n d

U n kyu Kim, PhD – 1998The Rockefeller Un i v e rs i t y

Jae Bum Kim, PhD – 1999M a s s a chusetts Institute of Te ch n o l o g y

Keiji Kimura, PhD – 1997Cold Spring Harbor Labo r a t o ry

D avid T. Kirkpatrick, PhD – 1998Un i v e rsity of North Carolina, Chapel Hill

R i chard Klinghoffer, PhD – 20 0 0Fred Hutchinson Cancer Res e a r ch Center

A n t h o ny J. Ko l e s ke, PhD – 1997Yale Un i v e rs i t y

Keith J. Kozminski, PhD – 1999 15

Un i v e rsity of California, Berkeley

Evert Kroon, PhD – 1999C l i n i cal Res e a r ch Institute of Montreal

Roland P.S. Kwok, PhD – 1997Un i v e rsity of Mich i g a n

Jongbum Kwon, PhD – 1999M a s s a chusetts General Hos p i t a l

M i chael Lagunoff, PhD – 1999Un i v e rsity of California, San Fr a n c i s c o

Siyuan Le, PhD – 1999Johns Hopkins Un i v e rsity School of Medicine

Sang Eun Lee, PhD – 20 0 0 16

Brandeis Un i v e rs i t y

Q i n tang Li, PhD – 20 0 0The Salk Institute for Biological Studies

Qing Liu, PhD – 20 0 0B righam and Wo m e n ’s Hos p i t a l

S h o u chun Liu, PhD – 20 0 0The Scripps Res e a r ch Institute

Christina Lopez-Rodriguez, PhD – 20 0 0H a rvard Medical Sch o o l

Jon R. Lorsch, PhD – 1998Stanford Un i v e rsity School of Medicine

Hong Luo, PhD – 1997M a s s a chusetts General Hos p i t a l

Xu Luo, PhD – 20 0 0Un i v e rsity of Texas, Dallas

Wallace Marshall, PhD – 20 0 0Yale Un i v e rsity School of Medicine

Fabio Martelli, PhD – 1998D a n a - Fa r ber Cancer Institute

Grant A. McArthur, PhD – 1998Peter MacCullum Cancer Institute

S t e ven B. McMahon, PhD – 1998P rinceton Un i v e rs i t y

D avid S. McNabb, PhD – 1997M a s s a chusetts Institute of Te ch n o l o g y

Raul Mendez, PhD – 1998Un i v e rsity of Massachusetts Medical Center

John Nip, PhD – 1998Vanderbilt Un i v e rsity School of Medicine

Christopher L. North, PhD – 1999H a rvard Medical Sch o o l

Masaki Okano, PhD – 1999M a s s a chusetts General Hos p i t a l

Barbara Dell Page, PhD – 1997Fred Hutchinson Cancer Res e a r ch Center

Manolis Pasparakis, PhD – 20 0 0Un i v e rsity of Cologne

Jonathan M. Passner, PhD – 1999Mount Sinai School of Medicine

Debananda Pati, PhD – 1999Texas Children’s Cancer Center

Garth Patterson, PhD – 1997R u t g e rs Un i v e rs i t y

Yuri Pe k a r s ky, PhD – 20 0 0Thomas Jefferson Un i v e rs i t y

P. Shannon Pendergrast, PhD – 1998 17

Cold Spring Harbor Labo r a t o ry

Gabriela C. Pe r e z - A l varado, PhD – 20 0 0The Scripps Res e a r ch Institute

Joel L. Pomerantz, PhD – 20 0 0C a l i f o rnia Institute of Te ch n o l o g y

Antonio A. Postigo, MD, PhD – 1999Washington Un i v e rsity

Pascal Preker, PhD – 20 0 0Un i v e rsity of California, San Fr a n c i s c o

Louise E. Purton, PhD – 1999Fred Hutchinson Cancer Res e a r ch Center

Vikram Rao, PhD – 1999H a rvard Medical Sch o o l

Alo Ray, PhD – 1999Cleveland Clinic Fo u n d a t i o n

Ra chel E. Rempel, PhD – 1997Duke Un i v e rsity Medical Center

Rolf Renne, PhD – 1997Case Wes t e rn Res e rve Un i v e rs i t y

N i cholas Rhind, PhD – 1999The Scripps Res e a r ch Institute

Christine Richardson, PhD – 1999 18


Anne Satterthwaite, PhD – 1998 19

HHMI, Un i v e rsity of California, Los Angeles

Brian Schaefer, PhD – 20 0 0National Jewish Medical & Res e a r ch Center

Clemens A. Schmitt, PhD – 20 0 0Cold Spring Harbor Labo r a t o ry

Brenda A. Schulman, PhD – 20 0 0M e m o rial Sloan-Ke t t e ring Cancer Center

J o a chim L. Schultze, MD – 1998D a n a - Fa r ber Cancer Institute

Jae Hong Seol, PhD – 20 0 0C a l i f o rnia Institute of Te ch n o l o g y

Thomas L. Serano, PhD – 20 0 0Un i v e rsity of California, Berkeley

Ke i - i chi Shabahara, PhD – 20 0 0Cold Spring Harbor Labo r a t o ry

Caroline E. Shamu, PhD – 1998H a rvard Medical Sch o o l

Virginia Smith Shapiro, PhD – 1998HHMI, Un i v e rsity of California, San Fr a n c i s c o

Robert Joseph Sheaff, PhD – 1997Un i v e rsity of Minnes o t a

Wu-Cheng Shen, PhD – 1998Un i v e rsity of Massachusetts Medical Center

Hyun Suk Shim, PhD – 1998Johns Hopkins Un i v e rsity School of Medicine

Protul A. Shrikant, PhD – 20 0 0R oswell Park Cancer Center

Julia Sidorova, PhD – 1999Fred Hutchinson Cancer Res e a r ch Center

D avid A. Sinclair, PhD – 1999M a s s a chusetts Institute of Te ch n o l o g y

Maria S. Soengas, PhD – 1999Cold Spring Harbor Labo r a t o ry

Lisa N. Spirio, PhD – 1998Whitehead Institute

Charles H. Spruck III, PhD – 1999The Scripps Res e a r ch Institute

S r i n i vasa M. Srinivasula, PhD – 20 0 0Kimmel Cancer Center

14 Dr. Irving is supported by a generous gift to theSociety from the Board of Trustees and Staff,Northern California Chapter.

15 Dr. Kozminski is supported in part by a generousgift to the Society from the Wayne & Gladys ValleyFoundation.

16 Dr. Lee is supported by a generous gift to theSociety from The Hildegarde D. Becher Foundation.

17 Dr. Pendergrast is supported by a generous gift to the Society from the Jane Elissa/Charlotte Meyers Fund.

18 D r. Richardson is supported by a generous gift tothe Society from the Vrushali Ranadave Fe l l o w s h i pEndowment Fu n d .

19 Dr. Satterthwaite is supported in part by agenerous gift to the Society from Parents AgainstLeukemia.

William L. Stanford, PhD – 1999 20

Lunenfeld Res e a r ch Institute

D avid Steger, PhD – 20 0 0Un i v e rsity of California, San Fr a n c i s c o

Re n a ta Stripecke, PhD – 1999Un i v e rsity of Southern Californ i a

M a s a h i ko Sugita, MD – 1999B righam and Wo m e n ’s Hos p i t a l

Susanne Szabo, PhD – 20 0 0H a rvard School of Public Health

Takashi Tanaka, PhD – 20 0 0H a rvard School of Public Health

A my H. Tang, PhD – 1998Un i v e rsity of California, Berkeley

Eduardo Sergio Tr o m b e t ta, PhD – 1998Yale Un i v e rsity School of Medicine

Vernon J. Two m b l y, PhD – 1999H a rvard Medical Sch o o l

Jessica Kate Tyler, PhD – 1998Un i v e rsity of California, San Diego

Hisse Martien Van Santen, PhD – 20 0 0H a rvard Medical Sch o o l

Jose A. Villadangos, PhD – 20 0 0The Walter and Eliza Hall Institute

Martin Villalba, PhD – 1999La Jolla Institute for Allergy and Immunology

Marie A. Vo d i cka, PhD – 20 0 0Fred Hutchinson Cancer Res e a r ch Center

M i chael We i n r e i ch, PhD – 1997Cold Spring Harbor Labo r a t o ry

Matthew D. We l ch, PhD – 1997Un i v e rsity of California, Berkeley

John C. Williams, PhD – 1999Columbia Un i v e rsity Health Sciences

Scot A. Wolfe, PhD – 1999M a s s a chusetts Institute of Te ch n o l o g y

Louisa Wu, PhD – 1997M e m o rial Sloan-Ke t t e ring Cancer Center

Lili Yamasaki, PhD – 1997Columbia Un i v e rsity Health Sciences

P. Renee Ye w, PhD – 1997Un i v e rsity of Texas, San Antonio

Ebrahim Zandi, PhD – 1998Un i v e rsity of Southern Californ i a

Martin Peter Zeidler, PhD – 1999H a rvard Medical Sch o o l

J i a n ke Zhang, PhD – 1997Un i v e rsity of California, Berkeley

Career Development—Fe l l o w s

Nagi G. Ayad, PhD – 20 0 0H a rvard Medical Sch o o l

Allison M. Baird, PhD – 1997Oregon Health Sciences Center

Janna Bednenko, PhD – 1999The Scripps Res e a r ch Institute

Kamel Benlagha, PhD – 1999P rinceton Un i v e rs i t y

I van Borrello, MD – 1998Johns Hopkins Un i v e rsity School of Medicine

Christine E. Brown, PhD – 20 0 0Pennsylvania State Un i v e rs i t y

Frank Bucholz, PhD – 1998Un i v e rsity of California, Berkeley

I m awati Budihardjo, MD, PhD – 1998HHMI, Un i v e rsity of Texas, Dallas

Elizabeth A. Burton, PhD – 20 0 0Duke Un i v e rsity Medical Center

Scott L. Butler, PhD – 1999The Salk Institute for Biological Studies

X i a o chun Cao, PhD – 20 0 0B righam and Wo m e n ’s Hos p i t a l

Paul A. Carpenter, MD – 1999Fred Hutchinson Cancer Res e a r ch Center

Giulia Celli, PhD – 20 0 0The Rockefeller Un i v e rs i t y

Raymond C. Chan, PhD – 1999Un i v e rsity of California, Berkeley

Feng Chen, PhD – 1999 21

HHMI, Stanford Un i v e rs i t y

Jiunn-Liang Chen, PhD – 20 0 0Johns Hopkins Un i v e rsity School of Medicine

A i yang Cheng, PhD – 20 0 0Yale Un i v e rsity School of Medicine

N i cholas D. Chester, PhD – 1997 22

H a rvard Medical Sch o o l

Tianhuai Chi, MD, PhD – 1997HHMI, Stanford Un i v e rs i t y

Penelope R. Chua, PhD – 1998Un i v e rsity of California, Berkeley

Jason Conaty, PhD – 20 0 0H a rvard Medical Sch o o l

Patricia D. Conrad, MD – 1999C h i l d r e n ’s Hospital of Philadelphia

Laurence J.N. Cooper, MD, PhD – 1999Fred Hutchinson Cancer Res e a r ch Center

Andrew Cuddihy, PhD – 1999Lady Davis Institute for Medical Res e a r ch

Sorab N. Dalal, PhD – 1997D a n a - Fa r ber Cancer Institute

L a x m i n a r ayana R. Devireddy, PhD – 1999Un i v e rsity of Massachusetts Medical Center

Fr e d e r i ck A. Dick, PhD – 1999M a s s a chusetts General Hos p i t a l

Andrew Thomas Dudley, PhD – 1998H a rvard Medical Sch o o l

Dominik Duelli, PhD – 20 0 0Cold Spring Harbor Labo r a t o ry

Charles L. Fa r n s worth, PhD – 1998H a rvard Medical Sch o o l

Adolfo Ferrando, PhD – 20 0 0D a n a - Fa r ber Cancer Institute

Monique Floer, PhD – 20 0 0M e m o rial Sloan-Ke t t e ring Cancer Center

Elsa Flores, PhD – 20 0 0M a s s a chusetts Institute of Te ch n o l o g y

R i chard Neil Freiman, PhD – 1999Un i v e rsity of California, Berkeley

Christopher Fr y, PhD – 20 0 0Un i v e rsity of Massachusetts Medical Center

Andrew J. Gale, PhD – 1997The Scripps Res e a r ch Institute

Fr a n ck Gesbert, PhD – 20 0 0D a n a - Fa r ber Cancer Institute

Indraneel Ghosh, PhD – 1999Yale Un i v e rsity School of Medicine

Ke ow Lin Goh, PhD – 20 0 0M a s s a chusetts Institute of Te ch n o l o g y

Felicia D. Goodrum, PhD – 1999P rinceton Un i v e rs i t y

Vi d ya Gopalakrishnan, PhD – 1997Johns Hopkins Un i v e rsity School of Medicine

Ti m o t hy Charles Grammer, PhD – 1998Un i v e rsity of California, Berkeley

Emir Hadzic, PhD – 1997The Rockefeller Un i v e rs i t y

Ti m o t hy J. Haggerty, PhD – 1998Johns Hopkins Un i v e rsity Medical Sch o o l

Ka tayoon Hojjati-Emami, PhD – 1999C a l i f o rnia Institute of Te ch n o l o g y

Nancy A. Hong, PhD – 1999Un i v e rsity of California, San Fr a n c i s c o

Duncan Howie, PhD – 1999Beth Israel Deaconess Medical Center

Yu chu Hsiung, PhD – 1997The Scripps Res e a r ch Institute

Xuejun Huang, PhD – 1999Un i v e rsity of California, San Diego

Ka t hyjo Jackson, PhD – 20 0 0Baylor College of Medicine

Eric Julien, PhD – 1999Cold Spring Harbor Labo r a t o ry

Janusz Ka b a r owski, PhD – 1999Un i v e rsity of California, Los Angeles

Robert E. Ka l e j ta, PhD – 1997P rinceton Un i v e rs i t y

H u n g -Ying Kao, PhD – 1998The Salk Institute for Biological Studies

Mark Kaplan, PhD – 20 0 0Un i v e rsity of Wisconsin, Madison

20 D r. Stanford is supported by a generous gift tothe Society from The Ka ryn Glick Res e a r ch Fu n d .

22 D r. Chester is supported by a generous gift to theSociety from The Hildegarde D. Becher Fo u n d a t i o n .

21 Dr. Chen is supported by a generous gift to theSociety from The Valley Foundation.

Ann Ke l l y, PhD – 20 0 0A m e ri can Red Cros s

Brian Ke n n e d y, PhD – 1997M a s s a chusetts General Hos p i t a l

Andrei V. Khokhlatch e v, PhD – 1999M a s s a chusetts General Hos p i t a l

Chang H. Kim, PhD – 1999 23

Stanford Un i v e rs i t y

Ta e - H young Kim, PhD – 20 0 0Un i v e rsity of Pittsburgh School of Medicine

Tatiana V. Ko l e s n i kova, PhD – 1999 24

D a n a - Fa r ber Cancer Institute

Rhett Kovall, PhD – 20 0 0Columbia Un i v e rsity Health Sciences

Yuen Yu Amy Lam, PhD – 1998Johns Hopkins Un i v e rsity School of Medicine

Douglas V. Laurents, PhD – 1997Instituto de Estructura de la Materi a

Bee-Na Lee, PhD – 1997H a rvard Medical Sch o o l

Sang Eun Lee, PhD – 1997Brandeis Un i v e rs i t y

Bibo Li, PhD – 1998The Rockefeller Un i v e rs i t y

Jianze Li, PhD – 1999Columbia Un i v e rsity Health Sciences

Yong Li, PhD – 1998HHMI, California Institute of Te ch n o l o g y

Monika Liljedahl, MD, PhD – 1999Un i v e rsity of California, San Diego

Young-Mi Lim, PhD – 1998Un i v e rsity of California, Los Angeles

Kuo-I Lin, PhD – 1999Columbia Un i v e rsity Health Sciences

M e e i -Yun Lin, PhD – 20 0 0Un i v e rsity of California, San Diego

Jinli Liu, MD, PhD – 1999Yale Un i v e rsity School of Medicine

D avid Loeb, MD, PhD – 20 0 0Johns Hopkins Un i v e rsity School of Medicine

Pei-Jung Lu, PhD – 1999Beth Israel Deaconess Medical Center

Biao Luo, PhD – 1999Whitehead Institute

Bart Lutterbach, PhD – 1998 25

Vanderbilt Un i v e rs i t y

Erik Martinez-Hackert, PhD – 1998 26

HHMI, Columbia Un i v e rs i t y

Lori F. Maxfield, PhD – 1998Tufts Un i v e rsity School of Medicine

Catherine J. McMahan, PhD – 1998Un i v e rsity of Wa s h i n g t o n

Taha Merghoub, PhD – 1999M e m o rial Sloan-Ke t t e ring Cancer Center

Nadeem Moghal, PhD – 1998HHMI, California Institute of Te ch n o l o g y

S h i vani Nautiyal, PhD – 1999Un i v e rsity of California, San Fr a n c i s c o

Erik Nelson, PhD – 20 0 0Beth Israel Deaconess Medical Center

Yael Nevo-Caspi, PhD – 1999Te l - Aviv Un i v e rs i t y

I ch i ko Nishijima, PhD – 20 0 0Baylor College of Medicine

Clodagh O’Shea, PhD – 1999Un i v e rsity of California, San Fr a n c i s c o

Koshi Oishi, MD, PhD – 1999Fred Hutchinson Cancer Res e a r ch Center

Paula M. Oliver, PhD – 1999National Jewish Medical & Res e a r ch Center

Kay Ke yer Opperman, PhD – 1999Johns Hopkins Un i v e rsity School of Medicine

Gabriela C. Pe r e z - A l varado, PhD – 1997The Scripps Res e a r ch Institute

Toni Portis, PhD – 1999Washington Un i v e rsity School of Medicine

Kiley Prillman, PhD – 20 0 0La Jolla Institute for Allergy and Immunology

Joe Ramos, PhD – 1997The Scripps Res e a r ch Institute

Hai Rao, PhD – 1998C a l i f o rnia Institute of Te ch n o l o g y

Karlyne M. Re i l l y, PhD – 1997H a rvard Un i v e rs i t y

Stephanie Anne Richards, PhD – 1998H a rvard Medical Sch o o l

Celeste Jeanne Richardson, PhD – 1999 27

H a rvard Medical Sch o o l

Stephanie E. Rieder, PhD – 1999The Scripps Res e a r ch Institute

S h r i kesh Sach d e v, PhD – 1999Ludwig-Maximilians Un i v e rs i t y

Thomas Schlindler, Dr Rer Nat – 20 0 0The Rockefeller Un i v e rs i t y

Catherine A. Schnabel, PhD – 1998 28


Roger Sciammas, PhD – 1998 29


JoAnn M. Sekiguchi, PhD – 1998 30

C h i l d r e n ’s Hospital Bos t o n

Paul Sincock, PhD – 1999Stanford Un i v e rsity School of Medicine

Cynthia Snyder, MD – 1997Un i v e rsity of New Mexico Health Sciences

Robert Sokolic, MD – 20 0 0M e m o rial Sloan-Ke t t e ring Cancer Center

S u p r i va Srinivasan, PhD – 1999 31

Un i v e rsity of California, San Fr a n c i s c o

Elaine E. Storm, PhD – 1998Un i v e rsity of California, San Fr a n c i s c o

S h u i chi Ta k ayama, PhD – 1998H a rvard Un i v e rs i t y

Wayne Tam, MD, PhD – 20 0 0Institute of Cancer Genetics

Idan Tamir, PhD – 1997National Jewish Center

Matthew Joseph Thomas, PhD – 1999Un i v e rsity of South Fl o ri d a

Randal S. Tibbetts, PhD – 1997Duke Un i v e rs i t y

Scott Tibbetts, PhD – 20 0 0Washington Un i v e rsity School of Medicine

M i chael Tomasson, MD – 1997B righam and Wo m e n ’s Hos p i t a l

Susheela Tridandapani, PhD – 20 0 0Ohio State Un i v e rs i t y

Chainarong Tu nyaplin, PhD – 1997Columbia Un i v e rsity Health Sciences

Indira Unnikrishnan, PhD – 1999Tufts Un i v e rsity School of Medicine

Kirsten K. Wa l ker, PhD – 1997The Salk Institute for Biological Studies

Pablo Wappner, PhD – 1997Weizmann Institute of Science

Tetsuro Wa tabe, PhD – 1998Un i v e rsity of California, Los Angeles

Julie Wilson-Annan, PhD – 1999The Walter and Eliza Hall Institute

Catherine A. Wo l kow, PhD – 1998M a s s a chusetts General Hos p i t a l

Dong Yu, PhD – 20 0 0P rinceton Un i v e rs i t y

Jinsong Zhang, PhD – 20 0 0The Rockefeller Un i v e rs i t y

Haiphong Zhong, PhD – 1998 32

HHMI, Yale Un i v e rs i t y

23 D r. Kim is funded by a generous gift to theSociety from Delora Sanfilippo in memory of HankM o rine and Bob Stauffer.

24 D r. Ko l esnikova is supported in part by agenerous gift to the Society from the Family of AnneRodin, in her memory.

25 D r. Lutterbach is supported by a generous gift tothe Society from The John and Shirley DaviesFo u n d a t i o n .

26 D r. Martinez-Hackert is supported by a generousgift to the Society from the Jane Elissa/CharlotteM e y e rs Fu n d .

27 D r. Richardson, The Glaxo Wellcome Gertrude B.Elion Fellow of the Leukemia & Lymphoma Society,is funded by a generous endowment from GlaxoWellcome Foundation and Glaxo Wellcome Inc.

28 D r. Sch n a bel is supported in part by a generousgift to the Society from The Valley Fo u n d a t i o n .

29 D r. Sciammas is supported by a generous gift to the Society from the Basso and the GaravanoFa m i l i es .

30 D r. Sekiguchi is supported by a generous gift to the Society from The Richard D. Fri s bee IIIFo u n d a t i o n .

31 D r. Srinivasan is supported by a generous gift to

32 D r. Zhong is supported in part by a generous gift to the Society from the Notarfrancesco Memori aGolf Outing.

Research grants—Translational Research Program

Robert Arceci, MD, PhD – 1997C h i l d r e n ’s Hospital Medical Center

D avid W. Bahler, MD, PhD – 1998Un i v e rsity of Pittsburgh

Albert Baldwin, PhD – 1997Un i v e rsity of North Carolina, Chapel Hill

E d ward D. Ball, MD – 1996Un i v e rsity of California, San Diego

Deborah E. Banker, PhD – 1998 33

Fred Hutchinson Cancer Res e a r ch Center

Peter Leif Bergsagel, MD – 1998Weill Medical College of Cornell Un i v e rs i t y

Ti m o t hy Bestor, PhD – 1998 34

Columbia Un i v e rsity Health Sciences

Ravi Bhatia, MD – 1999City of Hope National Medical Center

I van Borello, MD – 20 0 0Johns Hopkins Un i v e rsity School of Medicine

H. Scott Boswell, MD – 1998Indiana Un i v e rs i t y

M i chael Boyer, MD – 1999E m o ry Un i v e rs i t y

William L. Carroll, MD – 1999Huntsman Cancer Institute

Robert P. Castleberry, MD – 1998Un i v e rsity of Alabama, Birm i n g h a m

Kun-Sang Chang, PhD – 1998Un i v e rsity of Texas, Houston

Curt I. Civin, MD – 20 0 0Johns Hopkins Un i v e rsity School of Medicine

D avid Claxton, MD – 1997Un i v e rsity of Texas, Houston

John Colicelli, PhD – 1997Un i v e rsity of California, Los Angeles

Seth J. Corey, MD, MPH – 1997C h i l d r e n ’s Hospital of Pittsburgh

B h avana J. Dave, PhD – 1998Un i v e rsity of Nebraska Medical Center

Don J. Diamond, PhD – 1997City of Hope National Medical Center

John F. DiPersio, MD, PhD – 1998Washington Un i v e rs i t y

Ko n s tanze Dohner, MD – 20 0 0Un i v e rsity of Ulm

Daniel C. Douek, PhD – 1999 35

Un i v e rsity of Texas, Dallas

L. Austin Doyle, MD – 1998Greenbaum Cancer Center

Brian J. Druker, MD – 1996 36

Oregon Health Sciences Un i v e rs i t y

Robert Fenton, MD, PhD – 20 0 0Un i v e rsity of Mary l a n d

Harry W. Fi n d l e y, PhD – 1999E m o ry Un i v e rs i t y

Barry A. Finette, MD, PhD – 1997Un i v e rsity of Ve rm o n t

Rafael Fonseca, MD – 1998M a yo Clinic

Joseph Fo n tana, MD, PhD – 1998Wayne State Un i v e rs i t y

R i chard J. Ford, Jr., MD, PhD – 1998Un i v e rsity of Texas, Houston

Francine Foss, MD – 1996New England Medical Center

Arthur Edward Fr a n kel, MD – 1997Wake Fo r est Un i v e rs i t y

Patricia Fraser, MD, MPH- 20 0 0The Center for Blood Res e a r ch

Daniel P. Gold, PhD – 1999 37

Kimmel Cancer Center

Jianlin Gong, MD – 20 0 0D a n a - Fa r ber Cancer Institute

R i chard G. Gorlick, MD – 1999M e m o rial Sloan-Ke t t e ring Cancer Center

Els Goulmy, PhD – 1996Leiden Un i v e rsity Hos p i t a l

S t e ven Grant, MD – 1996, 20 0 0Virginia Commonwealth Un i v e rs i t y

Ti m o t hy C. Greiner, MD – 20 0 0Un i v e rsity of Nebraska Medical Center

Mark L. Heany, MD, PhD – 1998M e m o rial Sloan-Ke t t e ring Cancer Center

Guillermo Herrara, MD – 1997Louisiana State Un i v e rsity Medical Center

James Hnatyszyn, PhD – 1998 38

Un i v e rsity of Miami

Ronald Hoffman, MD – 1999Un i v e rsity of Illinois, Chica g o

Raymond Hohl, MD – 1998Un i v e rsity of Iowa

Marshall S. Horwitz, MD, PhD – 1999Un i v e rsity of Wa s h i n g t o n

Robert Hromas, MD – 1998Indiana Un i v e rs i t y

Frank James Hsu, MD – 1998Yale Un i v e rsity School of Medicine

Stephen P. Hunger, MD – 1998Un i v e rsity of Colorado Health S c i e n c es Center

M i chael Jensen, MD – 1998B e ckman Res e a r ch Institute

Daniel E. Johnson, PhD – 1999Un i v e rsity of Pittsburgh

Craig T. Jordan, PhD – 1998Un i v e rsity of Ke n t u cky Medical Center

R i chard P. Junghans, MD, PhD – 1998Beth Israel Deaconess Medical Center

Marshall Kadin, MD – 1997H a rvard Medical Sch o o l

Gregory J. Kato, MD – 1999Johns Hopkins Un i v e rsity School of Medicine

Emmanuel Katsanis, MD – 1998Un i v e rsity of Ari z o n a

Scott Kaufmann, MD, PhD – 1999M a yo Clinic

Brian K. Kay, PhD – 1998 39

Un i v e rsity of Wisconsin Medical Sch o o l

John T. Kemshead, PhD – 1997Un i v e rsity of Manch es t e r

Giemter Koehne, MD, PhD – 20 0 0M e m o rial Sloan-Ke t t e ring Cancer Center

Donald B. Kohn, MD – 1997C h i l d r e n ’s Hospital Los Angeles

Drishna V. Komanduri, MD – 20 0 0Un i v e rsity of Texas, Houston

S t e ven M. Kornblau, MD – 1999Un i v e rsity of Texas, Houston

Mark J. Ko u r y, MD – 1996Vanderbilt Un i v e rs i t y

Diane Krause, MD, PhD – 1998Yale Un i v e rsity School of Medicine

L awrence S. Lamb, Jr., PhD – 1999Palmetto Richland Memorial Hos p i t a l

Mary J. Laughlin, MD, MS – 1997 4 0

Case Wes t e rn Res e rve Un i v e rs i t y

Ming-Sheng Lee, MD – 20 0 0Un i v e rsity of Texas, Houston

Jean-Pierre Levesque, PhD – 20 0 0Peter MacCallum Cancer Institute

Bertrand C. Liang, MD – 1998Un i v e rsity of Ve rmont College of Medicine

D avid N. Liebowitz, MD, PhD – 1997Un i v e rsity of Pe n n s y l v a n i a

Jane Liesveld, MD; Jeffrey Lancet, MD – 2000 Un i v e rsity of Roch es t e r

T. Logtenberg, PhD – 20 0 0Un i v e rsity Medical Center Ut r e ch t

B. Jack Longley, MD – 1999Columbia Un i v e rsity Health Sciences

D avid G. Maloney, MD, PhD – 1999Fred Hutchinson Cancer Res e a r ch Center

Joan B. Mannick, MD – 1998D a n a - Fa r ber Cancer Institute

Ann Marshak-Rothstein, PhD – 1998B oston Un i v e rsity School of Medicine

William L. Marshall, MD – 1999D a n a - Fa r ber Cancer Institute

33 D r. Banker is funded by a generous gift to theSociety from The Chuck Griffin Memorial R es e a r ch Program.

34 D r. Bes t o r ’s grant is funded by proceeds from theWes t ch es t e r /Hudson Valley Chapter Annual Ball.

35 D r. Douek is supported by a generous gift to theSociety from the St. Va l e n t i n e ’s Day Luncheon &Style Show.

36 D r. Druker is supported in part by a generous giftto the Society from the G. Edward and Constance M.M i esel Family Fo u n d a t i o n .

37 D r. Gold is supported by a generous gift to theSociety by KEYS .

38 D r. Hnatyszyn is supported in part by a generousgift to the Society by The Gold-Diggers .

39 Dr. Kay is supported by a generous gift to the Society from the Northwestern MutualFoundation, Inc.

40 Dr. Laughlin, a Stephen Birnbaum TranslationalResearch Investigator, is funded by a generous gift to the Society from The Stephen BirnbaumFoundation.

Hector Martinez-Valdez, MD, PhD – 1998Un i v e rsity of Texas, Houston

W. Stratford May, Jr., MD, PhD – 1998Un i v e rsity of Fl o rida College of Medicine

Mark Minden, MD, PhD – 1999O n t a rio Cancer Institute

Ramzi Mohammad, PhD – 1996 41

Wayne State Un i v e rs i t y

Jeffrey Molldrem, MD – 1998Un i v e rsity of Texas, Houston

R i chard L. Momparler, PhD – 20 0 0Hopital Sainte-Justine

Tuna Mutis, MD, PhD – 1999Leiden Un i v e rsity Medical Center

Robert S. Negrin, MD – 1998Stanford Un i v e rsity School of Medicine

Giuseppina Nuchifora, DSc, PhD - 1999L o yola Un i v e rsity of Chica g o

Robert Zygmunt Orlowski, MD ,PhD – 1998 Un i v e rsity of North Carolina, Chapel Hill

L awrence Panasci, MD – 1998Lady Davis Institute for Medical Res e a r ch

Linda Z. Penn, PhD – 1998O n t a rio Cancer Institute

Sharon E. Plon, MD, PhD – 1998Baylor College of Medicine

Joseph Prchal, MD – 1997Un i v e rsity of Alabama, Birm i n g h a m

Shahin Rafii, MD – 20 0 0Weill Medical College of Cornell Un i v e rs i t y

S. Vincent Rajkumar, MD – 1999M a yo Clinic

Mariusz Z. Rarajczak, MD, PhD – 1999Un i v e rsity of Pe n n s y l v a n i a

Robert L. Redner, MD – 1999Un i v e rsity of Pittsburgh

Yair Reisner, PhD – 1998Weizmann Institute of Science

Benjamin E. Rich, PhD – 20 0 0B righam and Wo m e n ’s Hos p i t a l

Alain Rook, MD – 1997Un i v e rsity of Pe n n s y l v a n i a

S t e ven T. Rosen, MD – 1999 4 2

N o r t h w es t e rn Un i v e rs i t y

Joseph Rosenblatt, MD – 20 0 0Un i v e rsity of Roch es t e r

Leona Samson, PhD – 1998H a rvard School of Public Health

Daniela Santoli, PhD – 1998The Wistar Institute

Mathias Schmid, MD – 20 0 0Un i v e rsity of Ulm

J o a chim L. Schultze, MD – 1999D a n a - Fa r ber Cancer Institute

Paul Schwarzenberger, MD – 1997Louisiana State Un i v e rsity Medical Center

Paul Shami, MD – 1997, 20 0 0Un i v e rsity of Ut a h

Margaret A. Shipp, MD – 1997, 20 0 0D a n a - Fa r ber Cancer Institute

Donald Small, MD, PhD – 20 0 0Johns Hopkins Un i v e rsity School of Medicine

Roger Stair, MD, PhD – 20 0 0Un i v e rsity of Medicine & Dentistry of New Jers e y

R i chard A. Steinman, MD, PhD – 1998Un i v e rsity of Pittsburgh School of Medicine

Jeffrey W. Taub, MD – 1997Wayne State Un i v e rs i t y

Daniel G. Tenen, MD – 20 0 0Beth Israel Deaconess Medical Center

Nelson Teng, MD, PhD – 1997Stanford Un i v e rsity School of Medicine

Helen Tighe, PhD – 1999 4 3

Un i v e rsity of California, San Diego

Fatih M. Uckun, MD, PhD – 1998Wayne Hughes Institute

Jonathan Uhr, MD – 1997Un i v e rsity of Texas, Dallas

Marcel R.M. van den Brink, MD, PhD – 2000 M e m o rial Sloan-Ke t t e ring Cancer Center

Frits van Rhee, MD, PhD – 20 0 0Palmetto Richland Memorial Hos p i t a l

Ellen S. Vi t e t ta, PhD – 1997, 20 0 0Un i v e rsity of Texas, Dallas

Edmund Waller, MD, PhD – 1997E m o ry Un i v e rs i t y

Paul Weiden, MD – 20 0 0Virginia Masor Res e a r ch Center

Bruce Weinberg, MD – 20 0 0Duke Un i v e rsity Medical Center

Peter W. Wiernik, MD – 1998New York Medical College

Qing Yi, MD, PhD – 1999Un i v e rsity of Arkansas

James W. Young, MD – 1998M e m o rial Sloan-Ke t t e ring Cancer Center

Alice L. Yu, MD, PhD – 1998 4 4

Un i v e rsity of California, San Diego

John Yu, MD, PhD - 1997The Scripps Res e a r ch Institute

Xue-Zhong Yu, MD – 1999Fred Hutchinson Cancer Res e a r ch Center

Lisha Zhang, MD, PhD – 1999Un i v e rsity of Texas, Houston

41 D r. Mohammad is supported in part by agenerous gift to the Society from the Jim JacobsLeukemia Res e a r ch Fu n d .

4 2 D r. Rosen is supported by a generous gift to theSociety from the Dr. Ralph & Marion Falk Medica lR es e a r ch Tr u s t .

43 D r. Tighe is funded by a generous gift to theSociety from The Chuck Griffin Memorial Res e a r chP r o g r a m .

44 D r. Yu is supported by a generous gift to theSociety by KEYS .

Donors

Research

$1,000,000 and aboveUnited Food & Commercial WorkersInternational Union

$100,000-$499,999The Stephen Birnbaum FoundationJohn and Shirley Davies FoundationRalph & Marian Falk Medical Research Trust Glaxo Wellcome FoundationGlaxo Wellcome Inc.The Karyn Glick Special FellowshipLeslie Elliot Krause, Esq.Quality Food Centers/Chuck GriffinMemorial Research ProgramCarl Rosen Translational Research Fund

$50,000-$99,999Charities 2000Diamond Ball/Ed Heitz Memorial Research FundHildegarde D. Becher Foundation, Inc.Jane Elyssa/Charlotte Meyers FundPete HarmanJim Jacobs Leukemia Research FundPhilip OzerskyThe Reichman Memorial & The Altschul FoundationDelora SanfilippoDr. Scholl FoundationHarold Simmons Memorial GolfThe Valley Foundation

$10,000-$49,999Alabama Power CompanyAmerican AirlinesIn Memory of Dr. Jerry AndersonHamilton Ansley Research FundThe Beazley FoundationThe Berner Charitable and Scholarship FoundationBaker BottsHelen V. Brach FoundationThe Breeden-Adams FoundationCadillac PlasticsThe Gail Cohen Leukemia FundThe Coleman FoundationMr. Raymond M. Dunning, Jr.Mr. and Mrs. Craig EvansMr. and Mrs. Fred FischerThe Richard D. Frisbee I II FoundationGrant Healthcare FoundationKey Food Stores Foundation, Inc.KEYSF.M. Kirby FoundationCarmella KramerJim and Dixie KreiderBoard and Staff, The Leukemia &Lymphoma Society, NorthernCalifornia ChapterLewisville Memorial HospitalLocal 148 Operating EngineersMcCullough FoundationBob McKown Memorial Assoc.Mercedes Benz Credit Corp.NokiaNotarfrancesco Memorial Golf OutingNorthwestern Mutual Life FoundationParents Against LeukemiaEd & H Pillsbury FoundationPrefererd Health Systems

PricewaterhouseCoopers LLPPro-CutsThe Family of Ann RodinSigma Alpha Epsilon Fraternity,University of GeorgiaRobert Stiffel TrustSpeer, Leeds & KelloggMr. and Mrs. Gillis ThomasWest FamilyXcelerate Corp.

Patient Services

$100,000-$499,999Ortho Biotech

$50,000-$99,999AmgenGenentechNovartis

$10,000-$49,999The Stanley E. Brown FoundationCanyon Springs DevelopmentThe Entertainment Industry FoundationIDECMilwaukee FoundationNew York State Department of Health at therequest of Senator Charles J. Fuschillo, Jr .Pall Corp.Restaurant ConceptsSuperGenWyeth/Genetic Institute

Bone Marrow Drives

$10,000-$49,999The Everhealth FoundationF.M. Kirby FoundationMilwaukee FoundationThe Perfect Match Golf ClassicRotary International District 5130Rotary International District 5170

Total Program

$100,000-$499,99910th Annual San Antonio Golf ClassicChase Manhattan BankCitibank, NARush Limbaugh

$50,000-$99,999Cindy CrawfordVesta DurbinThe Robert R. McCormick TribuneFoundationMemorial Foundation, Inc.

$10,000-$49,999Andrew ArthurAuburn University/PanhellinicThe Sandra Atlas Bass and Edythe & Sol G.Atlas FundAlan BenaroyaLarry and Sherri BenaroyaMr. and Mrs. Joe BeseckerCatherine BoshawJames E. Bridge sThe Florence and Arthur BrockFamily FoundationScott BruinMr. & Mrs. Joseph Bruno

Canyon Springs DevelopmentCapital Group CompaniesCarrs-Gottstein Foods/SafewayCell Therapeutics, Inc.Central Texas Association of Bass ClubsDorothy M. CulbertsonFrances M. DayO. Paul Decker Memorial FoundationThe Draper FoundationEmployees Community Fund of Boeing St. LouisMarcel & Francine GaniWilliam and Nadine Gibson FamilyFoundationMark Grace FoundationHeinz USAThe Hellis FoundationHewitt Family FoundationHighmark BlueCross BlueShieldMargaret IngoldThe Dan Jansen Foundation, Inc.Kate M. Kelley FoundationKenetch Energy Systems, Inc.Jack J. Kessler, Esq.Mr. Sanjay KumarMario Lemieux Foundation Michael & Nicole LincolnJeffrey & Ingrid LionThe Marcus FamilyDouglas MarshallMark E. MasonBruce MatthewsMary Kay McCawThe McCutchen FoundationMike McKernanMicrosoftMichael NashSheryl & Peter NeupertThe New York Community TrustTom and Cathy O’KeefeMr. & Mrs. Richard G. PostMichael RonaSarver Charitable FoundationEdith M. Schweckendieck TrustsScott FoundationThe Sidney, Milton & Leoma SimonFoundationPhil and Sally SmartPhil Smart, Inc.Carmine SmeraldoSpeedway Children’s CharitiesGarrett Stauffer, CPATodd StottlemyreMichael SweigRobert & Jane TschudyUniversity Sports PublicationsRoseann Waindel FoundationWallmartCharles B. Wang FoundationWAWA IncorporatedHarry & Jeanette Weinberg Foundation, Inc.Wells Fargo BankMr. & Mrs. John C. WhetstonePamela WhortonStuart A. Williams, Esq.Rod Woodson

Organizational Partnerships

S p o n s o r s h i p s

$ 50 0 , 0 0 0 - $ 999 , 999Chase Manhattan Bank

$ 1 0 0 , 0 0 0 - $ 499 , 999A m e ri can Bicycle Association

$ 50 , 0 0 0 - $ 99 , 999A n chor Bancorp, Inc.Bank of Ameri caC h ry s l e r /P l y m o u t hC u m berland Pa cking Corp./Sweet ’N LowG e n e n t e ch, Inc./IDEC Pharm a c e u t i ca l sC o r p o r a t i o nM e r c e d es - B e n zNovartis OncologySallie MaeS a u c o ny T M

United AirlinesThe Wallis Fo u n d a t i o nThe Videre Group, LLP

$ 1 0 , 0 0 0 - $ 49 , 999Acordia South Fl o ri d aAd o be Systems, Inc.Alaska AirlinesAlliance SteelA m e ri can AirlinesA m e ri can Inves t o rsA m e ri t e chA n d e rsen ConsultingPeter & Georgia Angelos Fo u n d a t i o nA n h e u s e r - B u s chA rnold & Po r t e rAscension Pa rish Leukemia/CancerFu n d r a i s e rAT&T Fo u n d a t i o nB & B Washington's CatererBag & Save Superm a r k e t sBank OneBBDO Detroit, Inc.BellSouth MobilityBerlex Labo r a t o ri esBert Smith & Co.BET Holdings, Inc.Bitco Enterpri s esB l u e C r oss BlueShield of Californ i aB l u e C r oss BlueShield of MississippiB l u e C r oss BlueShield of New Jers e yBowne Business SolutionsBP AmocoB ristol My e rs SquibbB ritish Ae r os p a c eB ritish Airw a y sBrown & Wood LLPButera PropertiesC a m p bell & CompanyCapital OneC i n e r g yC l a r k /B a r d es, Inc.Classic Auto CouponsC l e a ry, Gottlieb, Steen & HamiltonCleveland Clinic Clipper NavigationC o m ca s tComercia BankComputer Science CorporationPhilip S. ContacosCorporate Express Business Interi o rsC ostco Wh o l es a l eCoulter Pharm a c e u t i ca l sR o bert CouryCredit Suisse/Fi rst Boston CorporationD i l Ch l AG

John and Shirley DaviesSusan Davis Intern a t i o n a lDeloitte & To u ch eDelta AirlinesD e u t s che Bank The Document Company - Xe r oxDodge DifferentDonaldson, Lufkin & JenretteHardy & Hayes, John D. BetresELG Haniel Metals Corp.Emily Water CompanyE ON, Inc.E rnst & Young LLPFannie Mae Fo u n d a t i o nFifth Third BankFight for ChildrenFood Service Management, Dominic Abbo t tFoodland Independent RetailersThe Ford Motor CompanyFreddie MacFutureNext Consulting, Inc.The GapGE LightingGetz Fo u n d a t i o nGibson Musical InstrumentsGoldman Sachs & Co.Grubb & EllisGwinnett Place HondaHalliburton Energy Serv i c esH a r ris BankH a r ris Beach Wi l c ox, LLPH a r ris Marketing GroupH e rshey Park Arena and Hock e yThe Hilton Wa s h i n g t o nHoenig & Co., Inc.Freddie HoffmanHoffman-La Roch eIBMI c o n i xIMC, Inc.Infinity Outdoor I n t e rnational House of Pa n ca k esJFK Medical CenterJohnson & JohnsonJohnson & Johnson Search Ameri caJ . P. Morgan & Co.John Ke l l e n y iKemira Pigments, Inc.Key BankKey Clubs of Central Pe n n s y l v a n i aKey Food Stores Foundation, Inc.Kirkland & EllisChildren of Maryanne & Henry J. Knott, Jr.Kojaian Management CorporationK PMG LLPLafarge Corp.Lake Stockton Ya cht ClubL a k eside Building MaintenanceLamarque Motor CorporationLaSalle BankTheodore Lazzaro, D.M.D., M.D., LTD .Leiner Health Products/Your Life Vi t a m i n sLevi Strauss & Co.L i berty Media HoldingsLitton PR CL o ckheed Martin Global Te l e c o m m u n i ca t i o n sLogicon Incorporated, a Northrop GrummanC o m p a n yL u n a r d i ’s Superm a r k e t sMargaret McCarthy Fo u n d a t i o nM a r riott Intern a t i o n a lM a rsh USA, Inc.Massey Charitable Tr u s tMBNAR ld M D ld H Ch iti

Mellon Bank Meltzer Schiner & Caroll, LLCM e m o rial HealthM e r cantile-Safe Deposit & Trust CompanyM e r chants BankM e r ck & Co., Inc.M e r rill Ly n chM e t a bo l i f eThe Mills CorporationMontpellier Res o u r c esMorgan Ke e g a nMorgan Stanley Dean Wi t t e rMike Munch a kNational City Bank, Pe n n s y l v a n i aNational Rural Ut i l i t i es Cooperative Fi n a n c eC o r p o r a t i o nThe Niello CompanyNo Name SteaksNorth Ameri can OperationsO r a c l eOrtho BiotechPat Gallagher, PGT Tr u cking Inc.PepsiCo Fo u n d a t i o nPe p s i - C o l aP f i z e r, Inc.P h a rmacia CorporationPhi Gamma Delta Fr a t e rn i t yPlanned Systems International, Inc.P l u m be rs & Pipefitters Local Union 72PNC Bank, Pittsburgh, PAP rice Modern, Inc.P ri c e w a t e r h o u s e C o o p e rs LLPProvident BankPutnam Allstate Ad v i s o rReliant EnergyRussell Reynolds AssociatesS&C Electri cS a f e c oSalomon Smith Barn e ySan Diego ChargersS ch e ring Labo r a t o ri esS e rvicemark Communica t i o n sS h e a rman & SterlingThe Sheakley Group of CompaniesSilicon GraphicsSmart DMS m i t h - C a i rn sSnyder Communications, Inc.S o n n y ’s Real-Pit Bar-B-QSony Digital Audio Disc CorporationS o u t h e rn Cultural Heritage CorporationS p e e r, Leeds & Ke l l o g gS p rint PCSStar Ac q u i s i t i o n sSteele Enterpri s esSTX, Inc.Sullivan Papain Block McGrath CannavoS u p e r Value, Pittsburgh, PASutler Cancer CenterTafel Motor CompanyTe l i g e n tTenet Louisiana HealthsystemR o bert E. Torray & Co. Inc.Tr a v e l e rs Expres sTu l l y ’s CoffeeTu rner ConstructionU k r o p ’sUn i v e rsity of Pittsburgh Medical CenterUPMC Health Systems US Airw a y sUUNETValley LexusVe rizon Communica t i o n sVirginia Oncology AssociationV l C f N th A i

Walt Disney Memorial Cancer Institute atFl o rida Hos p i t a lWashington GasWaste ManagementWatson Wyatt Wo r l d w i d eWB33 Chari t i es Fund of Robert R.M c C o rm i ck Tribune Fo u n d a t i o nWeil, Gotschal & Manges LLPWeitz & Luxenbe r gWells Fargo BankWh i t t m a n - H a r tWRQ, Inc.Yellow Corporation

P r o m o ti o n s

$1,000,000 and aboveThe Olive Garden Italian Res t a u r a n tD i a l A m e ri ca Marketing

$ 50 0 , 0 0 0 - $ 999 , 0 0 0KGO Newstalk AM81 0

$ 1 0 0 , 0 0 0 - $ 499 , 999Rhubarb JonesS C A NASunflower Opera CompanyWYAY- FM Y106.7 Hit CountryWBZ Chari t i es

$ 1 0 , 0 0 0 - $ 49 , 999Adelphia CableAzo, Inc.C a l i f o rnia-Nevada Operating EngineersCoastal CorporationCohutta Wa t e rC o i n s t a rH o o t e rsHouston Mercedes BenzInfinity Broadcasting Corp.J a z z e r c i s eJNS Consulting Engineers, Inc.The Kroger Co.K ZSN RadioLadd-Hanford Chry s l e r - P l y m o u t h - D o d g e -J e e p - M a z d aMighty Ta c oMiller Brewing CompanyMusic City 103Nashville SceneN o r t h w est Airlines AirCares ProgramO ’ C h a r l e y ’s, Inc.O u t b a ck SteakhousePennsylvania District Key ClubsPennsylvania Physicians CareRealm Charity GolfThe Regence GroupB l u e C r oss BlueShield of OregonB l u e C r oss BlueShield of Ut a hB l u e C r oss BlueShield of Wa s h i n g t o nRegence Life & HealthJ oseph Rosi JewelersSafeway Stores, Inc.S a t u rn of Harri s b u r gShults Fo r dS o u t h Pa r kThomas Sumter ACA DerryTimal Automotive Serv i c esVilla PizzaVolvo Cars of North Ameri caWFBQ Radio – The Bob & Tom ShowWIVB -TVW JYE - FMWZTV Fox 17

Report of independent auditors

Board of Tr u s t e e s

The Leukemia & Lymphoma Society, Inc.:

We have audited the accompanying consolidated statement of financial position of The Leukemia & Lymphoma Society, Inc. (the Society) as of June 30, 2000, and the related statements of activities, cash flows and functional expenses for theyear then ended. Th ese consolidated financial statements are the responsibility ofthe Society’s management. Our responsibility is to express an opinion on thes econsolidated financial statements based on our audit. The prior year summari z e dcomparative information has been derived from the Society’s 1999 consolidatedfinancial statements and, in our report dated September 30, 1999, we expressed an unqualified opinion on those statements.

We conducted our audit in accordance with auditing standards generallyaccepted in the United States of Ameri ca. Th ose standards require that we plan and perform the audit to obtain reasonable assurance about whether the financialstatements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financialstatements. An audit also includes assessing the accounting principles used andsignificant estimates made by management, as well as evaluating the overallfinancial statement presentation. We believe that our audit provides a reasonablebasis for our opinion.

In our opinion, the consolidated financial statements referred to above present f a i r l y, in all material respects, the financial position of The Leukemia & Ly m p h o m aS o c i e t y, Inc. as of June 30, 2000, and the ch a n g es in its net assets and its cash flowsfor the year then ended in conformity with accounting pri n c i p l es generally acceptedin the United States of Ameri ca .

O c t o ber 10, 20 0 0New York, New Yo r k

Consolidated Statement of Financial PositionThe Leukemia & Lymphoma Society, Inc.une 30, 2000 (with comparative amounts at June 30, 1999)

(in thousands)

See accompanying notes to consolidated financial statements.

2 0 0 0 19 9 9

A s s e ts

Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 11,114 $ 2 2 ,3 8 5Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1, 0 3 4 1,15 8L e gacies and contributions receivable (note 2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 , 59 8 2 ,115Prepaid expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 , 42 0 8 6 0Investments, at fair value (note 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67,35 4 4 0 , 5 4 4Equipment and leasehold improvements, less accumulated

depreciation and amortization of $1, 6 8 5 and $1,107 . . . . . . . . . . . . . . . . . . . . . . . . 2 , 478 1,8 0 5

Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 8 6 , 9 9 8 $ 6 8 ,8 67

L i a b i l i ties and Net Assets

L i a b i l i t i e s :

Accounts payable and accrued expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 7, 6 42 $ 6 ,79 6Deferred revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 , 413 2 ,7 74G rants payable (note 4) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 4 , 25 6 26 , 015

Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 5 ,311 35 , 5 8 5

Net assets:

U n r e s t r i c t e d . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 , 255 3 0 ,701Te m p o rarily restricted (note 7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,371 1, 6 0 8Permanently restricted (note 7) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1, 0 61 973

Total net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41, 6 87 33 , 28 2

Total liabilities and net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 8 6 , 9 9 8 $ 6 8 ,8 67

Consolidated Statement of Activitieshe Leukemia & Lymphoma Society, Inc.

Ye a r ended June 30, 2000 (with comparative totals for the year ended June 30, 1999) in thousands)

Te m p o ra r i l y Pe r m a n e n t l y To t a l

U n r e s t r i c t e d R e s t r i c t e d R e s t r i c t e d 2 0 0 0 19 9 9

O p e ra ting Re v e n u e

Campaign contributions . . . . . . . . . . . . . . . . . . . . . . . . . . $ 151,8 5 8 $ 3 0 5 $ 8 8 $ 152 , 251 $ 125 , 5 6 0Less direct donor benefit costs . . . . . . . . . . . . . . . . . . . . . (28 , 25 8 ) - - (28 , 25 8 ) (24 ,8 9 5 )

Net campaign contributions . . . . . . . . . . . . . . . . . . . . . . 12 3 , 6 0 0 3 0 5 8 8 12 3 , 9 93 10 0 , 6 6 5L e ga c i e s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 ,8 6 6 - - 5 ,8 6 6 3 ,3 41Net interest and dividend income (n o t e 3) . . . . . . . . . . . 2 , 0 07 19 - 2 , 0 26 1, 59 4Net appreciation in fair value of investments . . . . . . . . . . 6 53 10 3 - 75 6 1, 0 4 6G rant refunds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79 4 - - 79 4 52 9Net assets released from restrictions . . . . . . . . . . . . . . . . 6 6 4 ( 6 6 4 ) - - -

Total operating revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133 , 5 8 4 (2 37 ) 8 8 133 , 435 107,175

O p e ra ting Expenses (n o te 8 )

P ro g ram S e rvi c e s :

R e s e a r c h . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 ,197 - - 33 ,197 24 ,359Patient and community serv i c e . . . . . . . . . . . . . . . . . . . . . 35 , 2 0 0 - - 35 , 2 0 0 27,132Public health education . . . . . . . . . . . . . . . . . . . . . . . . . . 2 0 , 9 87 - - 2 0 , 9 87 16 , 939Professional education . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 ,72 2 - - 5 ,72 2 4 , 6 93Total program serv i c e s . . . . . . . . . . . . . . . . . . . . . . . . . . 9 5 ,10 6 - - 9 5 ,10 6 73 ,12 3

S u p p o rting S e rvi c e s :

M a n a gement and ge n e ra l . . . . . . . . . . . . . . . . . . . . . . . . . 8 , 9 8 3 - - 8 , 9 8 3 7,7 71Fund ra i s i n g . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 0 , 9 41 - - 2 0 , 9 41 15 , 626Total supporting serv i c e s . . . . . . . . . . . . . . . . . . . . . . . . 2 9 , 924 - - 2 9 , 924 2 3 ,397

Total operating expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125 , 0 3 0 - - 125 , 0 3 0 9 6 , 52 0

C h a n ge in net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 , 55 4 (2 37 ) 8 8 8 , 4 0 5 10 , 6 55

Net Assets

Beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 0 ,701 1, 6 0 8 973 33 , 28 2 2 2 , 627End of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 39 , 255 $ 1,371 $ 1, 0 61 $ 41, 6 87 $ 33 , 28 2

Consolidated Statement of Cash FlowsThe Leukemia & Lymphoma Society, Inc.Ye a r ended June 30, 2000 (with comparative amounts for the year ended June 30, 1999) in thousands)

2 0 0 0 19 9 9

Cash flows from opera ting acti v i ti e s :

C h a n ge in net assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 8 , 4 0 5 $ 10 , 6 55

Adjustments to reconcile change in net assets

to net cash provided by operating activities:

Net appreciation in fair value of investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . (75 6 ) (1, 0 47 )Permanently restricted campaign contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . ( 8 8 ) ( 5 8 0 )Depreciation and amort i z a t i o n . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 578 6 67

C h a n ges in assets and liabilities:

Decrease (increase) in accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124 ( 6 67 )Increase in legacies and contributions receivable . . . . . . . . . . . . . . . . . . . . . . . . . (4 8 3) ( 8 0 0 )Increase in prepaid expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1, 5 6 0 ) (3 0 3)Increase in accounts payable and accrued expenses . . . . . . . . . . . . . . . . . . . . . . 8 4 6 1, 524Increase in deferred revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 39 7 76Increase in grants payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 , 241 4 ,19 6

Net cash provided by opera ting acti v i ti e s . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 , 9 4 6 14 , 421

Cash flows from investing acti v i ti e s :

Purchases of equipment and leasehold improvements . . . . . . . . . . . . . . . . . . . . . (1, 251) ( 93 8 )Purchases of investments, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (26 , 0 5 4 ) ( 6 ,3 8 8 )

Net cash used in investing acti v i ti e s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (27,3 0 5 ) (7,326 )

Cash flows from financing acti v i ti e s :

Permanently restricted campaign contributions . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 8 5 8 0Net cash provided by financing acti v i ti e s . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 8 5 8 0

Net (decrease) increase in cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . (11, 271) 7, 675Cash and cash equivalents at beginning of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 2 ,3 8 5 14 ,710Cash and cash equivalents at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 11,114 $ 2 2 ,3 8 5


P r o g ram Serv i c e s S u p p o rting Serv i c e sPa t i e n t

a n d P u b l i c M a n a ge- Direct donorc o m m u n i ty h e a l t h P r o f e s s i o n a l ment and F u n d benefit costs

R e s e a r c h s e rv i c e e d u c a t i o n e d u c a t i o n To t a l ge n e ra l ra i s i n g To t a l 2 0 0 0 19 9 9 2 0 0 0 19 9 9

A w a rds and gra n t s . . . . $ 31,8 4 9 $ - $ - $ - $ 31,8 4 9 $ - $ - $ - $ 31,8 4 9 $ 2 3 , 4 9 5 $ - $ -

Financial aid to patients . - 3 ,8 0 8 - - 3 ,8 0 8 - - - 3 ,8 0 8 2 ,751 - -

S a l a r i e s . . . . . . . . . . . . . 24 9 12 ,752 6 , 251 2 , 251 21, 5 0 3 3 , 0 26 4 , 425 7, 4 51 28 , 9 5 4 2 2 , 24 9 - -

Employee benefits and taxes (note 5) . . . 4 4 2 ,32 9 1,351 4 57 4 ,181 6 31 1, 0 2 0 1, 6 51 5 ,8 32 4 , 0 61 - -

O c c u p a n cy (note 6) . . . 12 1, 4 4 4 8 8 2 316 2 , 6 5 4 4 07 6 0 9 1, 016 3 , 670 3 ,79 6 - -

I n s u ra n c e . . . . . . . . . . . . 4 10 5 73 2 0 2 0 2 33 67 10 0 3 0 2 28 6 - -

Te l e p h o n e . . . . . . . . . . . 8 6 97 6 62 13 8 1, 5 0 5 19 0 913 1,10 3 2 , 6 0 8 2 ,319 - -

Tra v e l . . . . . . . . . . . . . . . 2 9 78 9 4 5 4 162 1, 43 4 218 3 4 5 5 6 3 1, 9 97 1, 6 8 3 16 , 6 87 16 , 473

Printing and supplies . . 252 4 ,731 4 ,19 5 8 32 10 , 010 2 ,127 4 , 9 9 8 7,125 17,135 14 , 262 4 , 539 4 , 014

Equipment rentals . . . . 13 78 5 5 01 16 6 1, 4 6 5 2 3 0 3 8 6 616 2 , 0 81 1, 2 0 4 - -

Po s t a ge and shipping . . 3 6 2 ,137 2 , 2 2 2 392 4 ,787 5 4 0 3 , 0 59 3 , 59 9 8 ,3 8 6 6 ,8 35 - -

M e e t i n g s . . . . . . . . . . . . 142 1, 4 5 8 6 97 253 2 , 55 0 316 53 4 8 5 0 3 , 4 0 0 2 ,8 51 1,8 9 0 6 5 4

Professional fees . . . . . . 53 0 3 , 274 3 ,14 8 5 41 7, 4 93 1, 011 4 ,18 9 5 , 2 0 0 12 , 6 93 9 , 2 27 2 , 576 2 ,79 5

M i s c e l l a n e o u s . . . . . . . . 2 3 6 8 3 412 152 1, 270 19 0 27 7 4 67 1,737 8 3 4 2 , 5 6 6 9 59

Depreciation anda m o rt i z a t i o n . . . . . . . . 6 2 0 8 139 42 39 5 6 4 119 18 3 578 6 67 - -

Total expenses . . . . . . . $ 33 ,197 $ 35 , 2 0 0 $ 2 0 , 9 87 $ 5 ,72 2 $ 9 5 ,10 6 $ 8 , 9 8 3 $ 2 0 , 9 41 $ 2 9 , 924 $125 , 0 3 0 $ 9 6 , 52 0 $ 28 , 25 8 $ 24 ,8 9 5

Consolidated Statement of Functional ExpensesThe Leukemia & Lymphoma Society, Inc.Ye a r ended June 30, 2000 (with comparative totals for the year ended June 30, 1999) (in thousands)


To t a l

Fiscal year 2000 functional expenses

Research 26.5%

Patient and Community Service 28.2%

Public Health Education 16.8%

Professional Education 4.6%

M a n a gement and General 7.2%

Fund Raising 16.7%

Supporting Services23.9%

Program Services76.1%

Notes to Consolidated Financial Statementshe Leukemia & Lymphoma Society, Inc.une 30, 2000 (with comparative amounts as of and for the year ended June 30, 1999)

1. Organization and Significant Accounting Policies

OrganizationThe Leukemia & Lymphoma Society, Inc. (formerly Leukemia Society of Ameri ca ,Inc.) (the “Society”) is a national not-for-profit health agency dedicated to seekingthe cause and eventual cure of leukemia, lymphoma, Hodgkin’s disease and myeloma and improving the quality of life of patients and their families. The Soci-e t y ’s principal activities, which are conducted through its local ch a p t e rs and theHome Office, include: awarding res e a r ch grants; facilitating psych osocial supportgroups; providing financial aid to patients; answering phone requests for blood-related cancer information made to the Society’s Information Resource Center; anddisseminating educational information about blood-related ca n c e rs in the form ofp u b l i cations, internet sites and symposia sponsorship for both the medical commu-nity and the general public.

Tax-Exempt StatusThe Society qualifies as a ch a ritable organization as defined by Internal RevenueCode Section 501(c)(3) and, accordingly, is exempt from federal income taxes underI n t e rnal Revenue Code Section 501(a). Ad d i t i o n a l l y, since the Society is publicly-supported, contributions to the Society qualify for the maximum ch a ritable contri-bution deduction under the Internal Revenue Code.

Principles of ConsolidationThe accompanying consolidated financial statements include the accounts of theS o c i e t y, which encompasses the Home Office of the Society and its fifty-seven ch a p t e rs, as well as its not-for-profit affiliates, Leukemia Society Res e a r ch Pro-grams, Inc. and Leukemia Society of Ameri ca Res e a r ch Foundation. All significa n tintercompany and intra-Society accounts and transactions have been eliminated in c o n s o l i d a t i o n .

Net Asset ClassificationsTo ensure observance of limitations and res t rictions placed on the use of res o u r c esavailable to the Society, funds that have similar ch a r a c t e ristics have been classifiedinto three net asset ca t e g o ri es as follows:

Unrestricted net assets: Consist of funds that are fully available, at the discretion ofthe Board of Tr u s t e es, for the Society to utilize in any of its programs or supportings e rv i c es .

Temporarily restricted net assets: Consist of funds that are res t ricted by donors fora specific time period or purpose, as well as amounts relating to term endowmentor deferred giving arrangements in which the funds must be maintained intactover the lifetimes of the donors .

Permanently restricted net assets: Consist of funds that contain donor-impos e dr es t rictions requiring that the principal be invested in perpetuity and that only theincome be used. Income earned on these funds may be unres t ricted or temporari l yr es t ricted, depending upon the donor-imposed res t ri c t i o n s .

Contributions and Deferred Re ve n u eC o n t ributions are recorded as revenue, at their fair value, when received or promised unconditionally. Contributions received with donor res t rictions that limittheir use are reported as either temporarily or permanently res t ricted revenue.When a donor res t riction is met through the passage of time or fulfillment of ap u r p ose res t riction, temporarily res t ricted net assets are reclassified to unres t ri c t e dnet assets and reported in the statement of activities as net assets released from

r es t rictions. Te m p o r a rily res t ricted contributions that are received and expended inthe same period are reported as unres t ricted contributions. Conditional contri b u-tions are recognized as revenue when the conditions have been substantially met. Deferred revenue includes amounts received for special events that will be heldsubsequent to the fiscal year-end.

Donated ServicesA substantial number of volunteers have made significant contributions of theirtime to help develop the Society’s programs and activities. The value of such volun-teer serv i c es has not been reflected in the accompanying consolidated financialstatements as it does not meet the cri t e ria for revenue recognition.

Cash EquivalentsCash equivalents consist of money market accounts and short-term inves t m e n t swith a maturity of three months or less from date of purch a s e .

Equipment, Leasehold Improvements and DepreciationEquipment and leasehold improvements are recorded at cost, if purchased, or atfair value at date of donation, if contributed, and are depreciated or amortizedusing the straight-line method over the estimated useful lives of the assets or thet e rms of the leases, if shorter.

EstimatesThe preparation of financial statements in conformity with generally acceptedaccounting pri n c i p l es requires the Society’s management to make es t i m a t es andassumptions that affect the amounts reported in the financial statements andaccompanying notes. Actual results could differ from those es t i m a t es .

Summarized Financial InformationThe financial statements are presented with 1999 comparative information. Wi t hr espect to the statement of activities, such prior year information is not pres e n t e dby net assets class and, in the statement of functional expenses, 1999 expenses byobject are presented in total rather than by functional ca t e g o ry. Ac c o r d i n g l y, suchi n f o rmation should be read in conjunction with the Society’s 1999 financial state-ments from which the summarized information was derived.

2. Legacies and Contributions Receivable

The Society’s legacies and contributions receivable at June 30, 2000 and 1999 consist of unconditional promises to give, pri m a rily in the form of legacies forw h i ch the underlying wills have been declared valid by the probate court and noother conditions are required to be met. Amounts are scheduled to be received asfollows (in thousands):

2 0 0 0 19 9 9

Less than one year . . . . . . . . . . . . . . . . . $ 2 ,351 $ 1,8 6 8

A ft e r 5 years . . . . . . . . . . . . . . . . . . . . . . . 353 353

2 ,70 4 2 , 2 21

Less discount to present value(discount rate – 6.5%) . . . . . . . . . . . (106) (10 6 )

To t a l . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2 , 59 8 $ 2 ,115

3. Investments

The following is a summary of investments at June 30, 2000 and 1999 (in thou-sands):

Debt and equity securi t i es are recorded at fair value as determined by quotedmarket pri c es. Mutual funds are recorded at fair value using published unit values .I n v estment expenses of $172,000 and $132,000 have been netted against interest and dividend income for the years ended June 30, 2000 and 1999, res p e c t i v e l y.

4. Awards and Grants

Awards and grants for res e a r ch are recognized as expense in the year approved bythe Society’s Board of Tr u s t e es. Multi-year grants, which are generally two to fivey e a rs in length, are approved on an annual basis and may be terminated at the discretion of the Society’s Board of Tr u s t e es. In addition to unconditional grantsp a yable of $34 , 2 56,000 at June 30, 2000, the Society has grant commitments of$ 5 2 , 344,000 that are conditioned upon future events.

The Society has announced the creation of a major new res e a r ch program entitledSpecialized Centers of Res e a r ch (“SCOR”). In fiscal 2000, three of these five-yeargrants, each providing support of up to $1,500,000 per year and subject to annualr e v i e w, were awarded to cros s - d i s c i p l i n a ry res e a r ch teams based on a competitivereview of applications by the Society’s Medical and Scientific Committee.

5. Pension Plan

The Society has a noncontri b u t o ry, defined contribution 403(b) pension plan c o v e ring all employees meeting age and service requirements. Contributions arebased on a percentage of each eligible employee’s salary and years of service. In fiscal 2000, following a study of pension benefits provided by peer and otherorganizations, the Society enhanced its plan. Expense under this plan aggregated$ 1 , 1 81,000 and $694,000 for the years ended June 30, 2000 and 1999, res p e c t i v e l y.

6. Occupancy Expense and Lease Commitments

The leases for premises which the Society’s Home Office and ch a p t e rs occupy expireon various dates through June 30, 2010 and provide for certain payments subject toes calation and periodic rate increases relating to real estate taxes, operating expens-es and utilities.

In July 2000, the Society moved its Home Office from midtown Manhattan to Wh i t ePlains, New York, and entered into a ten year lease. Fi s cal 1999 occupancy expensei n c l u d es $700,000 related to the early termination of the New York City lease.

The approximate minimum future annual rental commitments, are summarized asfollows (in thousands):

7. Temporarily and Permanently Restricted Net Assets

Te m p o r a rily res t ricted net assets and the income earned on permanently res t ri c t e dnet assets were available for the following purpos es at June 30, 2000 and 1999 (int h o u s a n d s ) :

8. Joint Costs Allocation

In 2000 and 1999, the Society incurred joint costs for informational materials anda c t i v i t i es that included fund raising appeals as follows (in thousands):

In fiscal 2000, the Society adopted the provisions of AICPA Statement of Pos i t i o n( S OP) 98-2, “Accounting for Costs of Ac t i v i t i es of Not-for-Profit Organizations andState and Local Government Entities That Include Fund Raising.” Since the Societycontinued to meet the cri t e ria for allocation, the new SOP had no significant effect.

Ye a r ended June 30:

2 0 01 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 2 ,792

2 0 0 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 ,8 92

2 0 0 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 , 6 9 8

2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 , 261

2 0 0 5 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 ,73 0

T h e r e a ft e r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 ,125

To t a l . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $20,498

2 0 0 0 19 9 9Te m p o rarily Pe r m a n e n t l y Te m p o rarily Pe r m a n e n t l yRestricted Restricted Restricted R e s t r i c t e d

Research progra m . . . . . . . $ 6 0 5 $ 1, 017 $ 628 $ 93 0

Patient service andbone marrow donorp r o g ra m s . . . . . . . . . . . . . . 374 - 6 53 -

Professional educationp r o g ram . . . . . . . . . . . . . . . 5 0 4 4 4 0 43

O t h e rp r o g ra m s . . . . . . . . . . 3 42 - 287 -

To t a l . . . . . . . . . . . . . . . . . . . $ 1,371 $ 1, 0 61 $ 1, 6 0 8 $ 973

2 0 0 0 19 9 9

Fund ra i s i n g . . . . . . . . . . . . . . . . . . . . . . . . . . $ 9 ,332 $ 6 , 2 0 3

Patient and community serv i c e . . . . . . . . . . 1,315 1, 0 9 0

Public health education . . . . . . . . . . . . . . . 4 , 539 3 , 591

To t a l . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 15 ,18 6 $ 10 ,8 8 4

2 0 0 0 19 9 9Cost or Cost orDonated Fa i r Donated Fa i rVa l u e Va l u e Va l u e Va l u e

Money market funds . . . . . $ 35 ,325 $35 ,325 $ 14 , 552 $ 14 , 552

C o r p o rate notes and bonds . . . . . . . . . . . . . 14 , 0 9 9 14 , 2 0 9 15 ,10 8 15 , 074

Common stocks and mutual funds . . . . . . . . . . . 15 ,311 17, 2 0 0 7,8 55 9 , 259

U . S. Government o b l i ga t i o n s . . . . . . . . . . . . . 55 8 5 62 1, 6 0 9 1, 6 01

O t h e r . . . . . . . . . . . . . . . . . . 5 8 5 8 5 8 5 8

To t a l . . . . . . . . . . . . . . . . . . . $ 65,351 $ 67,35 4 $ 39 ,18 2 $4 0 , 5 4 4

National leaders

Chairman of the Board

J ay L. Silve rSugar Land, TX

Vice Chairman

Peter J. Quesenberry, MDP r o f essor of MedicineB oston Un i v e rsity (appointment pending)Director of Res e a r chRoger Williams Hos p i t a lProvidence, RI

Vice Chairman for Medical and S c i e n tific Affairs

W. Stratford May, Jr., MD, PhDD i r e c t o rShands Cancer Center, Un i v e rsity of Fl o rida G a i n esville, FL

S e c r e ta ry / Tr e a s u r e r

R i chard A. Fe s sP r es i d e n tM i d - Fl o rida Ag e n c i es of Orlando, Inc.Longwood, FL

N a tional Board of Tr u s te e s

Bruce H. AllenVice Pres i d e n tS u n Trust BankDelray Beach, FL

Fay AllenState Fa rm InsuranceJ e f f e rsonville, IN

Scott W. AllisonSenior Vice Pres i d e n tC o n n o rs Communica t i o n sSan Francisco, CA

Stephen M. BaileyAt t o rn e y - a t - L a wLittleton, CO

Irwin D. Bernstein, MDProgram Head, Pe d i a t ric Oncology ProgramFred Hutchinson Cancer Res e a r ch CenterSeattle, WA

Joseph E. Besecke rC h a i rman, President, and CE OEmerald Asset ManagementL a n ca s t e r, PA

Janis L. Biermann, MSD i r e c t o r, National Folic Acid CampaignM a r ch of Dimes Birth Defects Foundation White Plains, NY

Alexandra Mayes BirnbaumNew York, NY

M. O. BreedingOklahoma City, OK

Wilburn Brewer, Jr.Pa r t n e rNexsen Pruet Jacobs & Pollard, LLPColumbia, SC

Paul Calabresi, MDC h a i rman Emeritus, Department of MedicineBrown Un i v e rsity School of MedicineRhode Island Hos p i t a lProvidence, RI

Kathryn L. Calame, PhDDepartment of MicrobiologyCollege of Physicians and Surgeons Columbia Un i v e rs i t yNew York, NY

Robert A. "Spider" CantleyThe Insulation Co.Fremont, CA

John M. Coffin, PhDP r o f essor of MicrobiologyTufts Un i v e rsity School of MedicineB oston, MA

M i chael CopleyVice Chairman, Board of Tr u s t e esC h i l d r e n ’s Hospital Fo u n d a t i o nSan Diego, CA

James CoxP r es i d e n tDallas Mech a n i cal Air Sy s t e m sDallas, TX

Kathryn C. DanellaVice President and General ManagerB o ca Pointe Community Association, Inc.B o ca Raton, FL

D avid S. DimlingBoard of Ad v i s o rsEquity Capital Pa r t n e rs, Inc.Atlanta, GA

Cynthia M. DriscollFinance ManagerWomen & Infants Hospital of Rhode IslandProvidence, RI

Terri S. EdlundVice Pres i d e n tBank of Ameri caSan Antonio, TX

L awrence D. Ellis, MDP r o f essor of MedicineUn i v e rsity of PittsburghPittsburgh, PA

Stephen G. Emerson, MD, PhDChief, Hematology-OncologyUn i v e rsity of Pennsylvania School of MedicinePhiladelphia, PA

R i chard C. Fi cke nD i ck Fi cken & Associates, Inc.Eden Prairie, MN

Thomas L. Fi t z p a t r i ckManager of Corporate CreditSaint Gobain CorporationWo r c es t e r, MA

Frances M. Fox, RN, MSNCertified School Nurs eMt. Laurel, NJ

Paul N. Fr i m m e rIrell & Manella LLPL os Angeles, CA

Christine K. Fr i s b e eNew Canaan, CT

R i chard GarrisonP r esident and OwnerAdvertising Novelty Co., Inc.Washington, DC

John A. GeogheganGellert and Cutler, PCP u r chase, NY

Alan M. Gewirtz, MDStem Cell Biology and Therapeutic ProgramUn i v e rsity of Pennsylvania School of MedicinePhiladelphia, PA

Paul G. GlaabLaguna Niguel, CA

Keith P. HarendaP r es i d e n t / O w n e rK PH Construction, Corp.Wa u k esha, WI

Kathleen Hays, RN, MND i r e c t o r, Inpatient Oncology Serv i c esUn i v e rsity of Pittsburgh Cancer InstituteUn i v e rsity of Pittsburgh Medical CenterPittsburgh, PA

Pa t r i ck J. Healy, PhDSenior Vice President Finance and Ad m i n i s t r a t i o nQuinnipiac CollegeHamden, CT

Gary D. HirschC h a i rm a nElk Capital, LLCRye, NY

Lynn C. Hoove rM o r rison & Heck e r, LLPKansas City, MO

A n t h o ny L. HuffmanP r es i d e n t / O w n e rHuffman & Company, CPAJ a ckson, MS

Thomas F. HunterP r esident & COOFrequency Marketing, Inc.Milford, OH

William IannielloP r es i d e n tP r o f essional Painting, Inc.New Haven, CT

Anne K. JohnsonSenior Lending OfficerCTX MortgageSarasota, FL

Dan J. JordangerPa r t n e rHunton & Wi l l i a m sR i chmond, VA

John M. Ka m i n sPa r t n e rHonigman Miller Schwartz and CohnDetroit, MI

Judith E. Karp, MDP r o f essor of MedicineGreenebaum Cancer Center Un i v e rsity of Maryland Medical Sy s t e m sBaltimore, MA

Virginia Lee KintzMaster Long Te rm Care Repres e n t a t i v eGE Financial AssuranceS ch o h a rie, NY

Leslie Elliot Krause, Esq.Krause & Kr a u s eNew York, NY

William S. LearChief Financial OfficerBioSafe Medical Te ch n o l o g i es, Inc.C h i cago, IL

Diana LeeWi chita, KS

Lynna M. Lesko, MD, PhDSenior Associate DirectorI n t e rnational Clinical Res e a r chGeneral Medicine DivisionB o e h ringer Ingelheim Pharm a c e u t i cals, Inc.Ridgefield, CT

M i chael W. Long, PhDP r o f es s o r, Department of Pe d i a t ri c sM e m be r, Comprehensive Cancer CenterUn i v e rsity of Michigan Medical CenterAnn Arbo r, MI

Pasquale M. Lova s c i oHuntington Station, NY

Mark E. MasonVice Chairm a nOxford Development CompanyPittsburgh, PA

Catherine M. MattsonMarket Development ManagerHewlett Pa ck a r dR oseville, CA

Ronald P. McCaffrey, MDD i r e c t o r, The Cancer CenterLowell General Hos p i t a lLowell, MA

Thomas R. McDonaldTucson, AZ

John R. MohrP r es i d e n tJRM Communica t i o n sCold Spring Harbo r, NY

Dennis F. Moore, MD, FACPC h a i rman, Department of Hematology-M e d i cal OncologyWi chita Clinic, PAWi chita, KS

Virginia S. MorrisMedina, WA

Suzanne J. MuntzingWealth Management SpecialistWells Fa r g oSan Francisco, CA

Rodman N. Mye r sOf CounselHonigman Miller Schwartz and CohnDetroit, MI

Judge Robert H. NewmanMiami Beach, FL

Andrew E. NolanPa r t n e rP ri c e w a t e r h o u s e C o o p e rs LLPNew York, NY

Mary J. Oye rNorthfield, IL

Dominic PinoPa r t n e rP ri c e w a t e r h o u s e C o o p e rs LLPFt. Lauderdale, FL

D avid G. Po p l a ck, MDDirector Texas Children’s Cancer Center Houston, TX

D avid B. QuintySenior Resident Vice Pres i d e n tM e r rill Ly n chB i rmingham, AL

Martin Ra u chO w n e rRE /MAX Schoolside REA LTORSC h eshire, CT

William H. Re i m e r sRegional Sales ManagerBowman Enterpri s es, Inc.J a cksonville, NC

Marcie Rehmar Ro g e l lCommunity Educa t i o nC h i l d r e n ’s Hos p i t a lColumbus, OH

Naomi Rosenberg, PhDP r o f es s o rTufts Un i v e rsity School of MedicineB oston, MA

Kevin R. Rya nYa m p o l s k y, Mandeloff, Silver & Co.Philadelphia, PA

Donald H. SalsberyDirector of Fi n a n c eUFCWWashington, DC

Thomas J. ScanlonManaging Pa r t n e rDonahue & Sca n l o nCleveland, OH

Rhonda SheakleyCincinnati, OH

Frank T. ShortG o v e rnment Serv i c es DirectorLeagre Chandler and MillardIndianapolis, IN

Norbert J. SieberExecutive Vice Pres i d e n tMARC Ad v e r t i s i n gPittsburgh, PA

Kay H. Singer, PhDAssistant DeanDuke Un i v e rs i t yDurham, NC

Thomas R. Snyd e rFi rst Vice Pres i d e n tS u n Trust Bank, Nashville, NANashville, TN

James E. Sparke sManaging Pa r t n e r, Sy r a c u s eH a r ris Beach & Wi l c ox, LLPSyracuse, NY

Grant E. StebnerTigard, OR

Jeffrey N. Tr e n t o nP r es i d e n tProficiency Capital CorporationL os Angeles, CA

Joseph D. Verdirame, MDHematology & Oncology Consultants, PCOmaha, NE

William M. Ward, Jr.P r esident and CE OP r es b y t e rian Manors of Mid-Ameri caWi chita, KS

O wen N. Witte, MDDavid Saxon Presidential Chairin Developmental Immunology Howard Hughes Medical Institute/UCL AL os Angeles, CA

Judge Robert M. Ya c o b iWilliamsburg, VA

Joseph Yu r f e s tCWF Project DirectorC a r e Fi rst Blue Cross Blue Shield Timonium, MD

D wayne Howe l lP r esident and CE O

A d m i n i s tra ti o n

Cynthia Gardner CrossVice President Ad m i n i s t r a t i o n

C h a p ter Development

Paul We i s sSenior Vice President Chapter Development

Phil BoudreauRegional DirectorWes t e rn Region

Linda GruskiewiczRegional DirectorE a s t e rn Region

Pamela Byrne RileyRegional DirectorM i d w est Region

Ka t hy Vr o m a nRegional DirectorS o u t h e rn Region & Major Media Markets

F i n a n c e/I n f o r m a tion Te c h n o l o gy

John Wa l t e rSenior Vice President Finance & Information Te ch n o l o g y

J i m my NangleVice President & Controller Fi n a n c e

Stephen B. LucasChief Information Officer

Government & Le gi s l a tive Affairs

George DahlmanVice President Public Po l i c y

M a r k e ting & Communicati o n s

Robert K. We h r m a n nSenior Vice Pres i d e n tMarketing & Strategy Development

M i chael F. AldrichVice Pres i d e n tMarketing and Product Development

Kenneth R. LightcapVice Pres i d e n tC o m m u n i ca t i o n s

Pa tient Serv i c e s

Robin Kornhaber, MSWVice Pres i d e n tPatient Serv i c es

Research & Medical Progra m s

Marshall A. Lichtman, MDExecutive Vice Pres i d e n tR es e a r ch & Medical Programs

Alan Kinniburgh, PhDVice Pres i d e n tR es e a r ch Ad m i n i s t r a t i o n

Revenue Development

R i chard J. Geswe l lSenior Vice Pres i d e n tRevenue Development

Greg ElfersVice Pres i d e n tCampaign Development

Senior staff

Chapter offices (alphabetical by state)

Alabama

Alabama Chapter100 Chase Park South, Suite 220Birmingham, AL 35244Phone: (205) 989-0098

Arizona

Desert Mountain States Chapter2990 E. Northern Avenue, E-100Phoenix, AZ 85028Phone: (602) 788-8622

California

Greater Los Angeles Chapter100 Corporate Pointe, Suite 18 0Culver City, CA 9023 0Phone: (310) 348-5721

Northern California Chapter1390 Market Street, Suite 1200San Francisco, CA 9 4102-5306Phone: (415) 625-1100

Greater Sacramento Area Chapter 3105 Fite Circle, Suite 101Sacramento, CA 95827Phone: (916) 369-7581

San Diego/Hawaii Chapter4715 Viewridge Avenue, Suite 110San Diego, CA 92123Phone: (858) 277-1800

Tri-County Chapter1744 W. Katella, Suite 8Orange, CA 92867Phone: (714) 633-6858

Colorado

Rocky Mountain Chapter5353 W. Dartmouth AvenueDenver, CO 80227Phone: (303) 984-2110

Connecticut

Connecticut Chapter300 Research Parkway, Suite 310Meriden, CT 06450Phone: (203) 379-0445

Fairfield County Chapter25 Third Street, 4th FloorStamford, CT 06905Phone: (203) 967-8326

Delaware

Delaware Chapter100 West 10th Street, Suite 209Wilmington, DE 19801Phone: (302) 661-7300

District of Columbia

National Capital Area Chapter5845 Richmond Highway, Suite 630Alexandria, VA 22303Phone: (703) 960-1100

Florida

Central Florida Chapter3319 Maguire Blvd., Suite 101Orlando, FL 32803Phone: (407) 898-0733

Northern Florida Chapter9143 Phillips HighwaySuite 130, Exchange SouthJacksonville, FL 32256Phone: (904) 398-4845

Palm Beach Area Chapter4360 Northlake Boulevard, Suite 10 9Palm Beach Gardens, FL 33410Phone: (561) 775-9954

Southern Florida Chapter3325 Hollywood Boulevard, Suite 400Hollywood, FL 33021Phone: (954) 458-105 0

Suncoast Chapter13907 N. Dale Mabry Highway, Suite 101Tampa, FL 33618Phone: (813) 963-6461

Georgia

Georgia Chapter2625 Cumberland Parkway, Suite 205Atlanta, GA 30339Phone: (770) 438-6006

Illinois

Illinois Chapter100 W. Monroe, Suite 1610Chicago, IL 60603Phone: (312) 726-0003

Indiana

Indiana Chapter921 E. 86th Street, Suite 205Indianapolis, IN 46240Phone: (317) 726-2270

Kansas

Kansas Chapter555 N. Woodlawn, Bldg. 1, Suite 113Wichita, KS 67208Phone: (316) 687-2222

Mid-America Chapter6811 West 63rd StreetCloverleaf Building #1, Suite 202Shawnee Mission, KS 66202-4001Phone: (800) 256-1075

Kentucky

Kentucky Chapter710 West Main Street, Suite 201Louisville, KY 40202-2690Phone: (502) 584-8490

Louisiana

Louisiana Chapter3636 South I-10 Service Rd., Suite 304Metairie, LA 70001Phone: (504) 837-0945

Maryland

Maryland Chapter8600 LaSalle RoadChester Building, Suite 314Baltimore, MD 21286-2011Phone: (410) 825-2500

Massachusetts

Massachusetts Chapter495 Old Connecticut Path, Suite 220Framingham, MA 01701-4567Phone: (508) 879-5083

Michigan

Michigan Chapter1421 E. Twelve Mile Road, Bldg. AMadison Heights, MI 4 8071Phone: (248) 582-2900

Minnesota

Minnesota Chapter5217 Wayzata Blvd., Suite 221St. Louis Park, MN 55416Phone: (612) 545-3309

Mississippi

Mississippi Chapter405 Fontaine Place, Suite 103Ridgeland, MS 39157Phone: (601) 956-7447

Missouri

The Gateway Chapter77 West Port Plaza, Suite 101St. Louis, MO 63146-3111Phone: (314) 878-0780

Nebraska

Nebraska Chapter2665 Farnam StreetOmaha, NE 68131Phone: (402) 3 44-2242

New Jersey

Northern New Jersey Chapter45 Springfield AvenueSpringfield, NJ 07081Phone: (973) 376-9559

Southern New Jersey Chapter216 Haddon Avenue, Suite 328Westmont, NJ 08108Phone: (856) 869-0200

New Mexico

New Mexico Chapter3150 Carlisle, N.E., Suite 35Albuquerque, NM 87110Phone: (505) 830-6040

New York

Central New York ChapterLearbury Centre, 401 N. Salina StreetSyracuse, NY 13203-1770Phone: (315) 471-1050

Long Island Chapter555 Broad Hollow RoadMelville, NY 11747Phone: (631) 752-8500

New York City Chapter475 Park Avenue South, 21st Floor New York, NY 10016Phone: (212) 448-9206

Upstate New York/Vermont Chapter6 Automation LaneAlbany, NY 12205Phone: (518) 438-3583

Westchester & Hudson Valley Chapter20 Haarlem AvenueWhite Plains, NY 10603Phone: (914) 949-0084

Western New York & Finger LakesChapter5500 Main Street, Suite 110Williamsville, NY 14221Phone: (716) 635-9111

North Carolina

North Carolina Chapter5950 Fairview Road, Suite 25 0Charlotte, NC 28210Phone: (704) 998-5012

Ohio

Central Ohio Chapter145 North High Street, Suite 800Columbus, OH 43215Phone: (614) 221-3129

Northern Ohio Chapter20525 Center Ridge Road, Suite 630Cleveland, OH 44116Phone: (440) 333-5033

Southern Ohio ChapterFourth and Race Towers105 West Fourth Street, Suite 900Cincinnati, OH 45202Phone: (513) 361-2100

Oklahoma

Oklahoma Chapter3613 N.W. 56th Street, Suite 230Oklahoma City, OK 73112-4520Phone: (405) 943-8 888

Oregon

Oregon Chapter6501 S.W. Macadam AvenuePortland, OR 97201Phone: (503) 245-9 866

Pennsylvania

Central Pennsylvania Chapter800 Corporate Circle, Suite 100Harrisburg, PA 17110Phone: (717) 652-6520

Eastern Pennsylvania Chapter2401 Pennsylvania Avenue, Suite 2-D-1Philadelphia, PA 19130Phone: (215) 232-1100

Western Pennsylvania & West VirginiaChapterTwo Gateway Center, 13 North Pittsburgh, PA 15222Phone: (412) 395-2873

Rhode Island

Rhode Island Chapter75 Sockanosset CrossroadSuite 206 - Box 8099Cranston, RI 02920Phone: (401) 943-8888

South Carolina

South Carolina Chapter1247 Lake Murray BoulevardIrmo, SC 29063Phone: (803) 749-4299

Tennessee

Tennessee Chapter446 Metroplex Drive, Suite A-200Nashville, TN 37211-3139Phone: (615) 331-2 980

Texas

North Texas Chapter12850 Spurling Drive, Suite 190Dallas, TX 75230Phone: (972) 239-0959

South/West Texas Chapter950 Isom Road, Suite 10 4San Antonio, TX 78216Phone: (210) 377-1775

Texas Gulf Coast Chapter10777 N.W. Freeway, Suite 600Houston, TX 77092Phone: (713) 680-8088

Virginia

Virginia Chapter2101 Executive Drive, Tower Box 21Hampton, VA 23666Phone: (757) 838-9351

Washington

Washington/Alaska Chapter2030 Westlake AvenueSeattle, WA 98121Phone: (206) 628-0777

Wisconsin

Wisconsin Chapter1126 South 70th Street, Suite N405AMilwaukee, WI 53214Phone: (414) 256-4020

Helping the Society through effective personal financial planning

There are several convenient ways you can direct your personal financialplans to support the fight against blood-related cancers:

• Include The Leukemia & Lymphoma Society in your will and leave a lastinglegacy. You can direct gifts to be made in a specific amount, a percentageof your estate, or the remainder of your estate.

• Include The Leukemia & Lymphoma Society in your estate plans, a n dbecome a member of The Le g a cy Circ l e. Members receive regular u p d a t e son the progress being made in the fight against blood-related cancers andare invited to attend meetings with researchers.

• Consult with The Leukemia & Lymphoma Society to find out the best wayto use your trust, insurance policy or other estate planning technique inthe fight against blood-related cancers.

For more information, contact the Society’s National Director of Planned Giving at 1. 8 0 0 . 7 73 . 9 9 5 8 .

Co

nta

ct1311 Mamaroneck AvenueWhite Plains, NY 10605Tel: 914.949.5213Fax: 914.949.6691

www.leukemia-lymphoma.org

relentless cures for the - leukemia & lymphoma society · relentless about raising the money...

Documents